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Abstract
Nucleic acid self-assembly is a branch of nanotechnology that consists in the use of DNA
and RNA, not only as genetic material, but also as structural medium. In the last 30 years
this technique developed from the simplest structures into more refined constructions that
could require thousands of interacting sequences.
DNA origami were presented by Rothemund as the evolution of DNA assemblies. Origami
are nanostructures formed by a long single strand, the scaffold, held together by many
shorter oligonucleotides, the staples. Later research showed how to functionalize the
origami staples increasing the applicability.
Bacteriophage genomes were used as convenient source of single stranded DNA scaffold.
Today the potential biotechnological applications require to be bio-orthogonal and easily
transferable from academic research to industrial ones. To solve these problems we can
rely on the powerful tools of synthetic biology.
I focused on the synthesis, analysis and application of synthetic scaffolds based on the
combinatorial De Bruijn (DB) sequence. DB scaffolds are designed to be bio-orthogonal,
uniquely addressable and thermodynamically optimized.
I demonstrated their folding efficiency in DNA origami and RNA/DNA hybrid origami.
DB scaffolds were analyzed in vivo in E. coli to asses their bio-orthogonality.
Finally I designed a research tool to improve our knowledge on origami folding dynamics.
The system includes functionalized origami encapsulated in giant unilamellar vesicles.
The system allows the analysis of the origami using high throughput technologies, and
can simulate a simple cell-like environment facilitating the intermediate steps towards the
in vivo origami folding.
With my interdisciplinary approach I contributed to the advancement of nucleic acid
origami technology, taking advantage of tools and techniques from synthetic biology, origin
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In 1959 Richard Feynman envisioned the idea of nanotechnology in his lecture ”There’s
plenty of room at the bottom”. In his futuristic talk Feynman described the possibility
to arrange atoms in a controlled manner, to build medical nanodevices (”swallowing the
doctor”) and miniaturized factories. Even if 20 years in advance, he managed to foresee
the technological revolution that happened in the 1980s when finally scientists were able
to control the matter down to the single atom, allowing us to write a book smaller than
the head of a pin. In 1986 K. Eric Drexler added the concept of molecular nanotechnology
to the equation, surely inspired by Feynman’s talk and by the growing knowledge of bio-
logical systems. One of its most discussed aspects is the idea of a replicating nanorobot,
or self-replicating nanomachine. Different interpretations of this idea can be found in
disciplines once considered very distant: from the cellular self-replicating machinery in
biology, to the Von Neumann universal constructor in computing science.
In my dissertation I will try to bring these concepts together using the tools of biotechnol-
ogy, synthetic biology and nanotechnology with the support of computing science provided
by our interdisciplinary team.
To do so I spent my Ph.D. working on one of the most exciting topics in the recent years:
nucleic acid origami, a technology that uses nucleic acids as construction material to pro-
duce a wide array of designs in the nanometric scale. This technique, developed in 2006 by
Paul Rothemund, permits the building of complex nanomachines using DNA and RNA in
a bottom-up manner. It greatly improved the previous attempt to control DNA assembly
and immediately gained the scientific spotlight on a Nature cover. Nucleic acid nanotech-
nology does not see the genetic material just as data storage system, it also considers
19
20 CHAPTER 1. INTRODUCTION
the chemical and physical characteristics of these versatile molecules: the high specificity
of the Watson and Crick base pairing, the bio-compatibility, the controllable secondary
structures and of course the growing opportunities in synthesis and modifications. The
costs for the synthesis are following Moore’s law and the costs for the sequencing are drop-
ping even faster, making nucleic acids a promising material for the next breakthrough.
Being a biological component, nucleic acids can also rely on the natural replication system
inside the cell, a replication system to which we gained access and control through well
established biotechnological tools. Compared to chemical synthesis, the cell replication
machinery is even more efficient, granting a potential output far greater than our actual
necessities.
The tools I just described are extremely powerful, nonetheless a key factor is still lack-
ing to complete the picture, that is the implementation of the various components on a
common platform. The long-term vision behind my dissertation is to use the bacterial
cell as the platform, exploiting its internal systems as a nanodevice factory, integrating in
its very own genome the tools to control it, to achieve a biological universal constructor.
This idea reverses the common approach to the Von Neumann universal constructor, i.e.
adding a replication mechanism to a cellular automata, and instead the goal becomes
implementing a control system into an already replicating organism and transform it in
a programmable universal constructor.
One of the greatest challenges is given by the extreme complexity of the cellular envi-
ronment. Even though our knowledge on -omics is evolving at a fast pace, it is still very
difficult to predict all the connection between cellular pathways. The solution designed
to tackle this problem is a step-by-step approach, optimising the components in vitro,
testing them into a synthetic system and finally integrate everything in vivo. This pro-
cedure will grant an easier way to identify problems and bottlenecks, it will also allow to
use the matured knowledges in a modular fashion, as components for other applications.
1.1 Problem statement
Nucleic acid origami great potential is starting to be translated in industrial and medical
applications. Nonetheless there are still many issues that could hinder its biotechnological
value, amongst them the most relevant I can identify are: the widespread use of natural
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genomes as scaffolds, the fact that molecular dynamics ruling its folding are still partially
unclear and the lack of an in vivo origami synthesis route.
The first issue, the use of natural genetic material, derives from the difficulty of gener-
ating a long single strand DNA (ssDNA) molecule. M13 phage genomic DNA was the
first source of scaffold used for DNA origami [1]. It is a native ssDNA molecule and
this is its greatest advantage, it is also commercially available and it is very cheap to
produce, the phage infects E. coli injecting it with its genome, and replicates it and its
structural proteins inside the bacteria. All these characteristics are very good from a
research-oriented point of view and makes it the most widespread scaffold. At the same
time it carries great disadvantages when it comes to applicability. The main issue is given
by the presence of many repetitions, these repeated sequences can be long up to 42 nu-
cleotides and they cause misfolding of the nanostructures by presenting more than one
binding site for a single staple [2]. When this happens it lowers the yield of the origami
and sometimes it could be very difficult or impossible to separate the correctly formed
origami from the misfolded ones. Natural sequences can also form secondary structures
with very high thermodynamical stability that interfere with the staples binding. So far
the best way to perform an origami folding using a natural scaffold requires a first step of
denaturation at very high temperatures and then a slow gradual cooling down to avoid
the formation of kinetic traps. This protocol is obviously not compatible with many living
organisms, especially those of industrial interest. Finally, natural scaffolds are encoding
active genetic material: genes and regulatory sequences. An M13 scaffold or other active
genetic material can be a cause of safety concern if we want to design in vivo medical
applications, and it is an even bigger problem if we want to insert the origami in living
bacteria. Mutagenesis of these sequences can be only a partial solution because some of
the genes, especially those related to the phagic replication, cannot be changed without
compromising the scaffold synthesis. Other solutions considered the use of plasmid se-
quences as scaffold but in this case the production is time consuming, less efficient and
still carries over some biologically active sequences like origin of replication and antibiotic
resistances [3, 4]. An ideal solution would be to have an optimized fully synthetic sequence
that could be tailored each time to the desired application. Sequences that would not
interact with cellular components in unspecific ways. designed to perfectly fit the desired
structure.
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The second major issue is easily identifiable as an opportunity: a deeper knowledge of the
thermodynamical processes involved in the folding is not only of great scientific interest
but could also dramatically improve the transfer of the whole technology in vivo. Our
group is already active in the optimization of synthetic scaffold sequences and the de-
velopment of a computational origami folding model. To further improve this effort it is
necessary to develop a biological system capable of generating collectible data, a system
that could analyze the folding as it happens and detect the oddities and the unknown fac-
tors. An ideal tool would allow to characterize in which order and at what temperatures
the staples are folding the scaffold.
The last critical step towards the in vivo folding is the understanding of the relationship
between the origami components and the hosting cell. Optimal in vitro conditions are
extremely different from those found in any cytoplasm, prokaryotic or eukaryotic, we can-
not expect that the known protocols will work without major adjustments. The passage
through these systems could take advantage from a synthetic biology tool that allows a
progressive transposition granting the ability to work on the single issues without the
”background noise” generated in a complete living cell.
1.2 Aims and objectives
The main goal of my dissertation is the advancement of nucleic acid origami technique
towards the in vivo production and application, specifically into E. coli bacterial cell. To
reach the final goal I proceeded in a series of secondary subtasks that would be necessary
to, in the long run, achieve the ”holy grail” of a universal constructor.
1. Application of a De Bruijn designed scaffold to fold a nucleic acid origami: demon-
stration of the feasibility and applicability of a fully synthetic scaffold sequence. This
task addresses the issue of using a synthetic bio-orthogonal scaffold for advanced
applications.
2. Production of an hybrid RNA scaffold / DNA staples origami: the RNA scaffold
transcription is a step forward towards the in vivo synthesis. This task addresses
both the issues of using a synthetic bio-orthogonal scaffold and the production of
in− vivo origami components.
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3. Testing of the De Bruijn scaffold behaviour in vivo: the scaffold is tested inside an E.
coli cell to prove the bio-compatibility addressing the necessity for bio-orthogonality.
4. Design and testing of a De Bruijn origami reporter: the origami carries a fluorescent
molecular system that reports the folding in a real-time fashion. This experiment
addresses the needs for a better knowledge of the thermodynamic laws ruling the
origami folding.
5. Folding of the De Bruijn origami reporter inside a phospholipidic vesicle: the cell-like
system allows the study of the molecular events mimicking the in vivo conditions but
free of its perturbations. This complex task, in its variants, covers multiple issues:
it will allow to improve the thermodynamics knowledge, it will help to confirm the
bio-orthogonality of the synthetic sequences and it will accelerate the in vivo origami
research.
1.3 Structure of the dissertation
My thesis is composed of 3 main parts.
The first part includes: the analysis of the previous research on nucleic acid nanotechnol-
ogy and giant unilamellar vesicles, the literature review and a chapter on the experimental
and computational techniques I mastered during my Ph.D..
The second part is composed of four chapters and is focused on the experimental results:
one chapter about the DNA origami folded using a De Bruijn sequence generated scaffold,
one about the RNA/DNA hybrid origami using a thermodynamically optimised De Bruijn
scaffold, the third chapter contains the analysis of the previously used De Bruijn scaffolds,
cloned and transformed in a set of E. coli strains and the fourth chapter describes the
origami analysis tool based on the use of artificial liposomes.
The final part is the conclusion of my thesis, where I discuss the results and the future
opportunities of research provided by my work.
1.4 Main contributions
This research is a the true connector between the fields of bioinformatics and biology. My
work complements the PhD dissertation of Dr. Kozyra [5] which dealt primarily with the
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computational aspects of the origami folding, e.g. optimization via genetic algorithms.
My work is mainly concerned with the experimental challenges arising from Aims and
objectives 1.2. The application of the theory confirmed furthermore the utility of non
biological sequences, showing excellent folding ratios and improved thermodynamic pro-
files. These findings can easily be exploited both in research and industrial applications.
My work advanced then in the in vivo field. Cloning the synthetic scaffold in a bacterial
vector and expressing it inside E. coli is an important step towards the in vivo folding.
Different scaffolds gave different results showing the presence of factors still unknown and
worth of future research.
The vesicle-origami experiment generates a tool with a high potential research output.
This system can improve the understanding of the thermodynamic processes involved in
the origami folding giving a major contribute to synthetic biology, bioinformatics and
physics fields. This is the fruit of a highly interdisciplinary work set-up in collaboration
with Prof. Hanczyc at the University of Trento; connecting origami studies with the
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Chapter 2
Background and related work
2.1 Introduction
In this chapter I will introduce the topics discussed in my dissertation and analyse the
relevant literature summarising the state of the art.
2.2 Literature survey
2.2.1 Nucleic acid assemblies
Nucleic acid engineering is a promising field, due to the intrinsic characteristics of the
molecules themselves: biocompatibility, ease of replication and ease of further functional-
ising. In addition the generic advantages of the bottom-up approach [6], has made it one
of the key topics of recent molecular research. In particular, nucleic acid assembly is one
of the most interesting and fast developing technologies [7, 8]. Nucleic acid origami are
the main focus of my thesis. The technique, first published in 2006 [1], has deep roots in
the previous research on nucleic acid assemblies and nanostructures.
Going back to 1982, Nadrian Seeman published the first paper on nucleic acid junctions
and the related lattices, inspired by the DNA replicational junction and the recombina-
tion process in the form of the Holliday junction [9]. In this paper Seeman shows how it
is possible to control the shape of engineered nucleic acids molecules just exploiting the
Watson and Crick pairing. The DNA sequence is not encoding ”only” the genetic data,
but it also encodes the shape that the molecule will assume. Inspired by Escher’s painting
”Depth”, Seeman proposed also a theory of three-dimensional lattices, built using nucleic
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acid junctions connected by sticky-ends oligos, it was the beginning of the DNA based
nanoconstructs.
(a) (b)
Figure 2.1: 2.1a - M.C. Escher’s painting ”Depth”. 2.1b - Seeman’s DNA junctions
lattices. From reference [9]
The technique was soon refined by designing immobile junctions to stabilize the whole
structures [10]. The result was achieved by eliminating all the sequence symmetries at
the centre of the junction, so the strands cannot migrate on the adjacent bases. It was in
1993 that Seeman described the DNA double crossover molecules [11]. A double crossover
is a DNA structure where two Holliday junctions are connected by two helical arms [Fig.
2.2], thus, creating a much stabler DNA structure with a well defined structure and not
prone to any branch migration effect. This paper marked the second milestone in the
evolution of the technique and provided a push to the whole research field.
In 1996 the double crossover was applied as a nanoconstruction component [12]. In a
few years a plethora of new designs was published and the techniques were refined [13].
The rigidity granted by the double crossover molecules allows the formation of stable DNA
tiles, structures used as bricks in the building of biological self-assemblies [14]. At first
the tiles permitted the growth of geometric and periodic lattices but in a few years, with
new algorithm-driven designs, this technology allowed also the generation of aperiodic
and well defined structures [15, 16, 17, 18, 19, 20, 21, 22].
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Figure 2.2: Graphic representation of different DNA double crossovers. From reference
[11]
2.2.2 DNA origami
A major breakthrough in programmable nucleic acids engineering was made by Rothe-
mund in 2006 with the first DNA origami. This assembly technique involves the use of
a long single strand DNA molecule, the scaffold, which is folded in the desired shape by
the annealing of multiple smaller single strands DNA oligonucleotides, the staples, thus
recalling the Japanese art of folding paper [1] [Fig. 2.3]. Origami folding has many ad-
vantages over the previous assemblies, the most peculiar involving the reaction dynamics:
the origami works with an excess of staples over the scaffold and does not suffer from
any imbalance between the oligonucleotides, while the older DNA assembly protocols re-
quire a very strict stechiometric ratio between all the components. Moreover the folding
is obtained following a simple one-pot reaction protocol: all the components are mixed
together, heated up to a denaturing point and then slowly cooled to room temperature.
With this technique it is easier to build nanostructures of arbitrary shape and pattern,
and the fine placement of each staple grants a nanometric resolution, with the possibility
of ”decorating” each one of the staples.
Rothemund used M13mp18 genome, a phage, as scaffold for the origami. Being already
single stranded, a viral genome was a convenient scaffold for the origami folding in terms
of preparation and costs leaving to the synthesis only the shorter staples.
The design steps were computer-aided since the beginning and only the scaffold shape
was designed ”by hand”, first creating a block diagram with each block representing one
helix turn and then deciding the raster fill arrangement. All the staples related designs
were completed by CAD.
Such a powerful tool gained a central spot in the nanotechnology scene and soon many
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Figure 2.3: A graphic representation of an origami nanostructure. From reference [1]
groups started researching new upgrades and applications for this method.
Another groundbreaking evolution was published in 2009 when Douglas, in William
Shih’s group, folded the first 3D origami [23]. The 3D origami was folded by arranging
the scaffold in a honeycomb pattern, formed by the antiparallel helices sequentially angled
by 120◦[Fig. 2.4]. To achieve this result, the same lab developed a new CAD software
(caDNAno) that allows an easier design process for much more complex DNA structures
[24]. The software became one of the most used in the publications that followed, for its
intuitive and easy-to-learn user interface, and was soon integrated by a second software,
CanDo [25], able to predict the shape and stability of an origami design.
It must be noted that other groups folded DNA origami 3D structures in the same
year [26, 27] as the goal was considered of utmost importance for the evolution of the
nanostructure applications. Soon many new designs were published, defining new 3D
structures like nanotubules [28]
Shih’s team soon managed to generate a twisted 3D origami structure acting on the
number of base pairs between the crossing-overs [29]. DNA B helix has a 10.5 bp/turn
conformation, it means that, in a honeycomb lattice arrangement, two anti-parallel strands
can form a crossing-over every 7 nt (or every 120◦). Reducing or augmenting this number
forces the structures in a twisted conformation and could form angles up to 180◦. Benson
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Figure 2.4: (a) 3D origami folding schematic. (b) and (c) Cylinder model of folding
structure. (d) Atomistic model of 3D structure. From reference [23]
developed in 2015 an innovative 3D origami design [30]. Instead of using the classic
honeycomb raster design, that generates bricks filling the volume, they used a triangle-
based mesh that forms the surface of the origami leaving an empty volume on the inside.
The algorithm is designed to fold the scaffold in a linear way, avoiding the use of staples
connecting two distant points of the scaffold, and it can be considered as a viable option
for an in vivo folding, allowing the folding of an RNA scaffold as soon as it is transcribed
from the polymerase.
Over the subsequent years, many groups worked to improve origami folding protocols
under every aspect, aiming to find a better scalability that could boost the interest in the
applicability.
The original origami folding protocol can be considered quite extreme, especially if we
take in consideration the high denaturing temperatures necessary at the beginning of
the procedure, the particular ionic concentrations and the long times required by the
temperature ramps, that can be longer than a week for 3D origami. To overcome these
limitations many groups designed new protocols capable of solving one or more problems.
The addition of denaturing agents, as formamide and urea, was one of the first attempts
to achieve an isothermal folding [31]. On the other hand the purification steps proposed
involved toxic reagents and dialysis, requiring longer times and more difficult procedures.
Sobczak et al. managed to set up an isothermal protocol analysing the folding/unfolding
ratio through fluorescent dyes [32]. With this new protocol a 3D origami can be folded
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in two hours rather then two days, as previously required. This protocol achieved also a
higher yield of origami reducing the misfolding and the degradation resulting by long in-
cubation at high temperatures. In this research the initial denaturing step is still used and
not investigated. A further evolution of this protocol can be found in the work of Kopiel-
ski et al., in their protocol the lowest starting temperature is found by a trial and error
procedure, realising that there is no need for denaturation in a 2D origami folding using
Sobczak protocol [33]. Furthermore, using the additive betaine, they managed to reduce
the folding temperature to 37◦. Chopra investigated the addition of different molecules
other then magnesium or sodium salts. They folded different origami using spermidine, a
molecule know for DNA aggregation inside cells and viruses, spermidine made the origami
less salt dependent and resistant to electric fields as those used in electrotransfection [34].
Even if many different protocols are newly designed, the mechanics behind the origami
folding are not yet explained. An experiment based on a scaffold with multiple correct
foldings demonstrated though that the folding process follows a pathway [35]: a shape is
preferred over the others depending on the interaction of the staples in a long range and
locally.
The purification, ignored in the original publication by Rothemund [1], was initially per-
formed through agarose gel electrophoresis extraction [36]. Later, new purification meth-
ods were developed, aimed at improving the quality of the final product: PEG precipi-
tation [37, 38], ultracentrifugation [39], size exclusion by gel filtration [40], spin-column
filtration [41], magnetic bead capture and FPLC [42]. Each of the methods presents pros
and cons, and their suitability varies with the necessities.
DNA scaffold evolution
One of the most relevant aspects of the origami applicability passes through the scaffold
design and production. When Rothemund invented the technique, M13mp18 genome was
undoubtedly one of the cheapest and most convenient sources for a long single stranded
DNA molecule [1]. A limited choice availability, to a single scaffold, limits the range of
the features that one can design, and the use of genomic material also poses some limita-
tion on the possible customizations of the sequence. Nonetheless phage DNA production
scaling-up has been addressed, as the request of single strand DNA increased with the
origami popularity [43].
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Rolling circle amplification (RCA) is a replication system borrowed from phages. It has
been used to scale up the amount of origami components without recurring to solid-phase
synthesis. The first protocol has been designed just for staples synthesis. It can be per-
formed both in vitro and in vivo just changing few steps [44]. Later a new protocol was0
published, capable of synthesizing both scaffold and staples at milligram scale, using a
phagemid (a vector derived from phages) and a helper plasmid. The components are
encoded in the phagemid and spaced out by self-cleaving DNAzymes cassettes. When
the RCA synthesize the single strand DNA, the self-cleaving cassettes are activated by
zinc salts and cut themselves out of the sequence leaving the clean staples and scaffold in
solution. The whole system is cloned in E. coli and can be scaled up with the bacterial
culture [45].
The use of an hybrid phage DNA, fusing λ phage with M13, brought the size of the scaf-
fold up to 56 kilobases, though this scaffold is more prone to degradation than the much
shorter M13 [46]. The limitations in the origami size were also tackled by the develop-
ment of an advanced design algorithm capable of folding a fractal assembly of different
tiles from the same scaffold [47]. Though it works only on 2D origami, to a maximum of
8 by 8 tiles assembly, it can allow to fold a structure up to 0.5 square micrometres with
arbitrary patterns encoded on their surface.
Strategies that avoid the use of phage DNA have been also developed. The use of PCR
products or enzymatic digestion of plasmids were amongst the first attempts. PCR allows
the amplification a sequence of double stranded DNA from almost any template sequence
up to 35 kilobases [48]. It requires a second step to generate a single strand scaffold, and
different groups found different solutions to this problem, such as labeling one strand with
biotin and removing it after chemical denaturation [3], or selectively digesting the com-
plementary strand with a nuclease [4]. The digestion of a modified plasmid that encodes
a nicking enzyme site [49] generates a single stranded circular scaffold. Using high copy
numbers plasmids gives access to a scalable method to produce higher levels of starting
material than PCR. The use of double stranded DNA as scaffold has been studied too.
It has been used to fold two different origami, one for each strand [50], and as a single
origami structure with the two scaffolds converging without regenerating the original dou-
ble strand [51]. This strategy could drastically increase the availability of origami sources
but it did not prove to be efficient enough for larger or more complex designs with a high
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percentage of the scaffolds re-annealing back to the double strand conformation.
Many strategies were adopted to overcome the limitations imposed by the different scaf-
folds.
Supramolecular structures are one of the solutions to increase the size of the objects built
using origami. For example a tripod, built on a slightly modified M13mp18 scaffold, was
used as a brick to build regular polyhedra [52]. Interestingly, in the same article, a new
method is described for the detection of large origami using fluorescent ultra-resolution
microscopy.
Other tiles-like systems have been published for both 2D and 3D origami [53, 54]. Another
solution involves the stacking of different origami exploiting non-base pairing at particular
buffer conditions [55][Fig. 2.5]. With this method it is also possible to design a dynamic
structure controlling its shape by varying cationic forces and temperature. The evolution
of this technique, improving the rigidity of the DNA building blocks, allows the control
the formation of structures up to 1.2 gigadaltons [56].
A different approach was taken using a DNA origami as frame to assemble a DNA tile
system. With this method, the origami creates just a perimeter while the area is filled by
the tiles. This hybrid allows to increase the area of the assembly compared to an origami
with the same scaffold, at the same time the origami provide for the finite and controlled
shape of the assembly [57].
2.2.3 TectoRNA and RNA origami
Around 20 years after Seeman’s first publications on DNA assemblies the research on
nanoconstructions opened also to RNA. This branch, called tectoRNA, exploits the many
advantages associated with the RNA molecule. The most relevant difference with the ma-
jority of DNAs is the natural single stranded conformation, like the bacteriophage DNA,
RNA is ready to participate in an assembly. RNA can take advantage of the greater
interactivity typical of its secondary and tertiary structures and additional features can
be added to the assemblies, like hairpins, junctions and kissing-loop interactions, while
adapting the building strategies previously developed for DNA [58, 59, 60]. The advan-
tages of RNA are not limited to its structural versatility, when it comes to applicability
RNA shows a set of very attractive features as: an easy synthesis from a DNA template
with a promoted transcription, reducing costs and maximizing yields; a larger nucleobases
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Figure 2.5: (a) 3D origami stack schematics exploiting non-base pairing. (b) TEM imaging
of the stack. This technique takes advantage of the base stacking to connect multiple
origami in a 3D superstructure. From reference [55]
pool that allows greater pairing flexibility; better thermodynamic and pH stability that
increase the suitability for practical applications both in vitro and in vivo; and the op-
portunity to add biologically active sequences as ribozymes and sRNA [61, 62][Fig. 2.6].
Following the example of the DNA nanotechnology, new RNA assemblies were de-
signed. Initially simpler 2D structures were inspired or copied by natural RNA motifs,
like T and L junctions from transfer RNAs and ribosomial RNAs [63, 64]; soon evolving
in more complex assemblies with 3D structures [65] and functionalized strands [66].
To overcome the limitations of the tile structures, the technology of origami was developed
also for RNA. At first different groups arrived to the same result, an RNA scaffold folded
using DNA staples. Endo used a section of Enhanced-GFP coding region as template
for the scaffold [67], while Wang used a fragment of pUC19 plasmid [68]. Both groups
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Figure 2.6: Design steps for RNA nanotechnological devices.
obtained the folding of the origami adapting the structure of the helix from the B con-
formation of DNA-DNA interaction (10.67 bp per turn) to the A helix of the RNA-DNA
hybrid (11 bp per turn).
Endo prepared the first RNA origami [69], this time both the scaffold and the staples
were transcribed by T7 polymerase, the short DNA templates were modified with biotin
to remove them after the staple synthesis using streptavidin coated magnetic beads. The
optimal folding conditions and origami size matched those of RNA-DNA hybrid origami.
2.2.4 Origami applications
Many of the applications stem from the origami technology: the more theoretical proof-
of-concept studies, aimed to showcase the capability of the new techniques, like the DNA
motor origami track [40] or the single nucleotide polymorphism visual detector [70], and
the advanced biophysical and biomedical applications. These technologies take advantage
of the extreme variability permitted by the functionalization of the staples in a single
origami [71]. Various versions origami carriers for anti-cancer drugs are now in the spot-
light [41, 72]. In these systems staples are modified to target a specific cell type, to control
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Figure 2.7: Scheme of the origami folding using an RNA scaffold and DNA staples.
The scaffold was encoded in a pUC19 plasmid and amplified with a PCR, adding a T7
promoter through the primer. The PCR product was then transcribed to generate the
RNA scaffold. DNA staples oligos were added to fold the final origami. From reference
[68]
the opening and closing of the origami boxes, to bind and include the therapeutic drug
inside the origami. These particular nanorobots take advantage of the biocompatibility
of DNA to mask the drug presence to the body. The drug can not interact with the
system until it’s released, granting a double effect: the drug is targeted more finely to the
right tissues, reducing undesired collateral effects, and at the same time cancer cells can
not activate the drug-resistance systems until it’s too late to overcome the therapeutic
activity. Another origami interactive container has been designed by Takenaka [73]. In
this case the box is capable of capturing gold nanoparticles from the buffer solution, and
the origami lock is photoresponsive, it opens upon UV irradiation and closes with visible
light. Other DNA containers have been designed to achieve different functions as com-
partmentalization or controlling enzyme reactions [26, 74, 75]. DNA origami has been
designed also to interact with bacteria, in this case the structure is a DNA pyramid deco-
rated with glutathione-protected gold nanocluster (fluorescent reporter) and intercalated
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with Actinomycin D antibiotic. This delivery system increases the uptake of antibiotic
in E.coli and S.aureus by 50% [76]. Torelli designed a nanorobot capable of exposing a
payload, a DNAzyme, upon the hybridization to a single strand activating sequence [77].
Applications for origami can be found not only in the biological field but also in bio-
physics where the technique has been exploited to build a device that generates plasmonic
resonance of gold nanoparticles arranged with nanometric precision [78]. Another study
showed how DNA origami nanotubes could help the stabilization of membrane proteins
during NMR [37]. Given their nanometric precision, origami have been used as standards
and calibration tools in super-resolution microscopy and AFM [79].
Origami have been used also as platforms in nanotechnology and synthetic biology. He
built a self replicating system based on DNA rafts [80], the rafts can dimerize starting from
a single seed dimer, when cross-linked using UV sensitive molecules as linkers, the newly
formed dimers act as seeds and the growth become exponential. Taking advantage of pH
sensitive secondary structures, the system can be calibrated to prefer the dimerization of
specific tiles in a mixed environment.
One of the main questions related to the possible in vivo applications is the behaviour
of the origami inside a living cell. Mei et al. partially answered this question in 2011 show-
ing how a DNA origami resists in a cell-free extract from a mammalian cell line, up to 12
hours [81]. The experiment showed also that the origami can retain a specific interaction
activity with proteins. Different origami designs and cell lines were tested, the results
support the applicability as a detector for proteomics and intracellular environments.
2.2.5 In vivo assemblies and origami
The idea of exploiting the origami in vivo propelled the research toward the nanostructure
synthesis directly inside the cell, the first in vivo application of a nucleic acid assembly is
achieved by Delebeque in 2011. This is an important breakthrough because the oligonu-
cleotides are encoded in the cell through a plasmid and the nanostructures fold inside the
cell. The assemblies are functionalized with protein binding aptamers that bind target
oligopeptides fused to the enzymes of interest. The organizing activity is shown inside
an E.coli living cell by coupling the two halves of a split GFP back to its functional
structure, and augmenting an enzymatic pathway output spatially organizing two of its
components on the same scaffold [82].
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Figure 2.8: Graphic representation of the in vivo RNA scaffold. A and B are the two com-
ponents organized on the assembly. The assembly can further generate one-dimensional
(nanotubes) or two-dimensional (mesh) structures. From reference [82]
Based on this work, Sachdeva improved the system bringing the number of organized
enzymes up to four, using larger RNA tiles and optimizing both the aptamers and ligands
structures, obtaining an increase of 80% in a pentadecane production pathway in E.coli
[83], both of these works use a tiles assembly system, bringing over its limitations com-
pared to origami, most importantly: the necessity of a strict stechiometry amongst the
different components and the generation of non-discrete structures.
The nature of RNA brought Geary and Andersen to speculate on the possibility of
generating a tile-like structure just using a single self-interacting RNA scaffold. They
designed different configurations of it [84] and tested them in vitro [85]. This assembly
does not use any staple, instead it uses a single molecule of RNA that folds like a protein,
as soon as a domain is transcribed it folds on itself forming a secondary structure, in this
way the RNA molecule is more resistant to degradation. Once the secondary structures
are all formed, they interact to generate the tertiary structure that can be 2D or 3D. Not
requiring an initial denaturation, it is possible to perform a cotranscriptional folding in a
single step. Based on the same concept, in 2018 another single molecule RNA assembly
was designed, this time in vivo. The molecule is expressed through a plasmid in E.coli,
then extracted by phenol or sonication and the structure is analysed by atomic force
microscopy and cryo-EM [86]. Unfortunately no reporting system was used to demonstrate
the folding inside the cell. These single molecule RNA structures are very different from
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origami, their convenient folding procedure comes only after a molecular design that is
specific for every single sequence and there are no softwares comparable to CADnano to
simplify this procedure. Unlike the origami it is not possible to use the same scaffold to
produce different shapes and every time it requires at least a rearrangement of the domains
[87]. To make the design process easier, the critical junctions and structural corners are
often copied from biological sequences found in various organisms, including viruses and
bacteriophages [59]. On the contrary the origami shape can be changed with a new set
of staples with minimal effort, or it is possible to change its function substituting only
the functionalized staples and keeping the shape unaltered. The origami high number
of components, if from one side makes the folding more difficult, on the other allows for
a larger capacity of carrying active components, Elbaz designed a system to synthesize
single stranded DNA filaments in E. coli, up to 205 nucleotides long, using HIV and
murine leukemia reverse transcriptase. An assembly crossover made by four strands was
folded both in vitro or directly in vivo [88].
2.2.6 Giant unilamellar vesicles
The final part of my Ph.D. involved the use of a technology used in a different research
field than the previously described: the giant unilamellar vesicles (GUVs), a particular
kind of artificial liposomes. The literature on vesicles and micelles is extremely vast and
I will summarize only the aspects more relevant to my work.
This technology is of great interest in the study of bacterial division [89] and membrane
proteins [90], the synthesis of cytomimetic systems reproducing cellular conditions [91, 92],
the studies on the origin of life [93, 94] and the research in unconventional computing
[95]. The first protocol for artificial lipid vesicles was published in 1969 [96], this method
produces multilamellar vesicles, that consist in multiple concentric lipidic bilayers. In the
following years new synthesis processes were developed, capable of producing unilamellar
vesicles, single lipidic bilayers containing a controlled aqueous solution. Amongst them is
the inverted emulsion protocol published in 2003 by Pautot [97]. The procedure consists
in the passage of an inverted emulsion (aqueous droplets surrounded by a monolayer of
lipids) through a lipid/aqueous interface, because of the amphiphilic behaviour of the
lipids the second layer is captured around the droplet and the liposome is formed [Fig.
2.9]. A more detailed description of the protocol is found in section 3.8.
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Figure 2.9: Giant Unilamellar Vesicles synthesis using the inverted emulsion protocol. A -
The inverted emulsion is formed (droplet) preparing the first lipid layer. B - Preparation
of the aqueous-lipidic interface with the second lipid layer. C - The droplet passes through
the interface from the lipid to the aqueous phase, forming the lipid bilayer. From reference
[97]
The main advantage of this technique is the simplicity of the procedure that does
not require any special instrument. On the other hand all the steps require extra care
and must be executed in a very precise manner or the vesicles will not form, also, small
residues of the oil solution could contaminate the final product [89].
The product of the inverted emulsion protocol is a polydispersed mixture of GUVs with
dimensions that vary from 10 µm to 100 µm. The size of GUVs allows the use of optical
methods for their analysis.
Because of their composition and shape, GUVs has been used as compartments to perform
in vitro experiments simulating a cell environment without the background activity of a
living cell, Nishimura performed a GFP transcription inside a GUV containing a solution
of mRNA and cell-free extract [91].
Artificial vesicles are also used for the study of the membrane fusion processes, many fu-
sion protocols are described in literature, and I will only focus on those I consider relevant
42 CHAPTER 2. BACKGROUND AND RELATED WORK
for my research.
One of the first experiments involved the use of calcium ions to facilitate the vesicles
fusion, with the simple incubation of the vesicles in a solution containing Ca(Cl)2 [98].
Other metal ions were studied and characterized, in particular Mg2+ [99], that is of par-
ticular interest for its use in origami folding. A similar method was developed using a
polyethylene glycol (PEG) solution [100]. In all these cases the vesicles seem to fuse for the
dehydrating and effect of the fusing molecules and, in the case of metal ions, for the neu-
tralizing effect on the repulsion of the headgroups charges, enhancing the contact between
the membranes. The fusion between oppositely charged vesicles has also been observed
and characterized through microscopy [101] and flow citometry [102]. These vesicles are
synthesized using a mix of neutral and charged lipids, and the different compositions
naturally fuse if close enough.
2.3 Technical background
2.3.1 Gel electrophoresis
The first analysis performed on the origami is usually gel electrophoresis. This technique
allows the separation of nucleic acid molecules by charge and size: the sample is loaded in
a gel that acts as a molecular sieve and the applied electric field moves the nucleic acids,
negatively charged, towards the positive electrode. Smaller molecules will pass through
the gel net more easily and will form bands at the bottom of the gel. It can be per-
formed in agarose gels, for larger molecular weights, or polyacrylamide for smaller ones
or to achieve higher resolutions. Once the sample has run long enough to be separated
in clear bands, it can be visualized using fluorescent dyes that intercalates into the helix
like ethidium bromide or Sybr R© Gold.
The sample can also be recovered from the agarose gel using commercial kits, the band
of interest is cut from the whole gel and the nucleic acid is retrieved chemically or me-
chanically.
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2.3.2 Atomic force microscopy (AFM)
Atomic force microscopy is a scanning probe microscopy (SPM) technology that allows
to scan samples at sub-nanometric resolution. The main components are: a reflecting
piezoelectric cantilever which has a sharp tip at one extremity (the probe), a laser pointed
at the reflective surface of the cantilever into a photodiode detector and a scanner that
moves the sample. The instrument moves the surface under the tip in a raster pattern,
when the tip engage the sample the cantilever is deflected by the interaction with the
substrate, the piezoelectric current and the laser movements are collected by the detector
and translated into a topographic image [Fig. 2.10].
Figure 2.10: Diagram of AFM working principles. The sharp tip on the edge of the
cantilever reacts with the sample surface, its movements are detected by piezoeletric com-
ponents and by laser reflection, all the data are are electronically elaborated to reconstruct
the sample topografy.
The nucleic acid sample is immobilized on a mica surface, a mineral formation com-
posed of perfectly flat layers. Mica is negatively charged, to interact with nucleic acids it
is necessary to add a positive divalent ion that acts as a bridge [Fig. 2.11] [103, 104], the
most used are nickel or magnesium divalent ions.
AFM generates two-dimensional images from the surface so is recommended for 2D
origami.
2.3.3 Transmission Electronic microscopy (TEM)
Transmission electron microscopy is another technique capable of visualizing a sample at
nanometric scale. In this case the machine transmits a beam of electrons into a detector
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Figure 2.11: Interaction of DNA on mica in presence of positive divalent ions. From
reference [104]
after it passed through the sample. The origami sample is suspended on a metal grid and
pretreated with uranyl formate, a very electrondense salt that intercalates nucleic acids
blocking the electron beam, the sample looks like a shadow over the background (positive
staining technique).
With TEM it is possible to vary the depth of focus of the electron beam granting a better
insight on 3D origami structures [Fig. 2.12].
Figure 2.12: Example of TEM imaging on 3D origami. From reference [23]
2.3.4 Flow cytometry
Flow cytometry is the technology used to count and measure the fluorescence of E. coli
cells during the reporter gene experiments. A flow cytometer can analyse individual small
particles, like cells, in a high-throughput fashion. The main components of this machine
are: the flow cell where the sheath fluid carries the bacteria and aligns them in a single
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line; a laser system that excites the fluorophores and allows the measurement of light
scattering; the detectors and photodiodes to collect the signal.
Figure 2.13: Representation of flow cytometry principles.
2.3.5 Microplate reader
The analysis of the functionalized origami fluorescence was performed using a microplate
reader. This instrument, similarly to a flow cytometer, measures the intensity of the
fluorescence exciting the fluorophore through a laser light and collecting the signal with
a detector. In this case the sample is held in a microplate well and the operating volumes
can be miniaturized down to 20 µl.
2.3.6 pUC19 vector
pUC19 is a commercial cloning vector often used as DNA scaffold for origami. It is easy
to replicate and cheap to buy. The commercial version from New England Biolabs (NEB)
was used during this research. pUC19 is designed to have a multicloning site containing
different restriction enzyme sequences, a pMB1 origin of replication, a lacZ α gene and
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an ampicillin cassette [Fig. 2.14]. It has a GC content of 52%.
Figure 2.14: Map of pUC19 vector from NEB ??
2.3.7 Commercial nucleic acid synthesis
Synthetic sequences were purchased from IDT and Eurogentec as follow: Standard PCR
primers were purchased from Eurogentec. DB 2.4 biotinylated primers were ordered from
IDT. DB Tri was synthesized by Life Technologies while DB 981 was ordered from IDT
and both sequences were cloned in proprietary plasmids.
2.3.8 Nucleic acid concentration measurement
The concentration of nucleic acid was measured using a NanoDrop ND1000 spectropho-
tometer.
2.3.9 Nucleic acid storing
Nucleic acid products, purchased or synthesized in the lab, were divided in aliquots, stor-
ing part of them as stocks in the -80◦C freezer for longer conservation, and the remaining
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parts at -20◦C for rapid use.




Dealing with an interdisciplinary project requires to master a set of techniques originating
from very different research fields In this chapter I will describe the most important in
order to understand the experiments.
3.1 Nucleic acid origami
The origami folding requires a two-steps approach: first a computer aided design and
then the actual folding using wet-lab techniques. The next paragraphs will examine each
single step in detail.
3.2 Origami computational design and De Bruijn se-
quence
The design step of an origami is a complex matter, especially for larger origami. Further-
more any thermodynamical optimization increases exponentially the workload required to
reach a final design. During the years many research groups developed computer-aided-
designing (CAD) tools aimed to make this step less requiring in terms of knowledge and
more user-friendly. Two software packages were used for the basic design of the origami
in this research: CADnano [23], and CanDo [25]. The first software allows the design
of 2D and 3D DNA structures, while the second simulate the final structure showing its
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stability.
The origami sequences optimization and the results are described in detail in Dr. Kozyra
Ph.D. thesis [5].
The study focused on the properties of mathematical sequences, in particular the so called
De Bruijn sequences, replacing the natural scaffolds so to improve the controllability of
the folding process. By definition, De Bruijn (DB) sequences are ”non-biological” and
”highly addressable”, hence programmable. ”Non-biological” simply means that it has
no comparable known sequences in nature, while ”highly addressable” is a term borrowed
from computer science and it means that for each staple sequence domain there is only
one scaffold complementary target. A DB DNA or RNA sequence is composed of a four
nucleotide alphabet, in predefined sub-sequences of k nucleotides length, that appear just
once in the whole main sequence (no sequences long as k or longer are repeated), giving
it a unique addressability while working with k long sub-units (or longer). The sequence
can be described as B(4, k) [Fig. 3.1]. By this rule, and using just the four natural


































Figure 3.1: De Bruijn DNA sequence based on a 3 nucleotides subunit set, each triplet is
included only once in the whole sequence. From reference [2]
The combinatorial system needed to design a long DB sequence requires a computing
aid that was developed by Dr. Kozyra and used together with the standard softwares
described above.
The DB scaffolds were furthermore improved and made bio-orthogonal by removing all
the parts matching E.coli K12 sequences recorded in the PRODORIC database [105], and
removing the most common restriction enzymes selected from the New England Biolabs
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Table 3.1: The table shows that the De Bruijn sequences (DBS) have no common se-
quences with E.coli K12 and the most common NEB restriction enzymes, while the stan-
dard scaffold sequences match them extensively. From reference [2]
online database [Tab. 3.1]. The sequences were also checked against BLAST, showing no
relevant alignments with any other recorded sequence.
The sequences also meet a series of predefined characteristics as thermodynamic sta-
bility, avoidance of secondary structures and transcription efficiency. The sequences were
selected after a structural analysis performed with ViennaRNA package [106] and then
refined removing the unwanted characteristics.
The design process involved a continuous dialogue between biological and computational
groups, feedback from the laboratory results provided new inputs for the in silico analysis
in a classical design-validation cycle. The final result consists in two DB sequences, one
DNA scaffold of 2.4 kb and one RNA scaffold of 1Kb.
3.3 Molecular computational design
3.3.1 Plasmid design
All the plasmids were designed using the Benchling on-line platform (https://benchling.com)
especially the Molecular Biology Design and Analysis Suite. This on-line lab note allows
the design of biological parts, the annotation and further elaboration with convenient
tools for PCR, digestions and sequence alignments.
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3.3.2 Aptamer design
The analysis and design of the aptamers was performed on NUPACK (http://www.nupack.org),
an online software suite used to predict the secondary structure of nucleic acids at the
equilibrium. It can be used for both DNA and RNA and it allows to combine multiple
strands with different sequences and concentrations.
3.4 Molecular laboratory methods
Here I will describe the technologies I used to build and analyse the genetic constructs
used to study the scaffolds in vivo and inside the vesicles.
3.4.1 Plasmid transformations and extractions
The first necessary step, to produce a scaffold, is the transformation of the vectors in the
bacteria. Each plasmid was transformed in E. coli 5-α competent cells (NEB), a stan-
dard cloning strain, the transformations were performed following the heat-shock protocol
suggested by the NEB kit manual. The transformed cells were streaked on agar plates
and incubated at 37◦C overnight using the proper antibiotic for the selection: kanamycin
50 µl/ml for DB transformants and ampicillin 100 µl/ml for pUC19 transformants. The
next day a colony was inoculated in 7 ml of LB broth and antibiotic and grew overnight.
Two stocks for each strain were prepared mixing 750 µl of culture with 750 µl of glycerol
50% and stored them at -80◦C. The remaining culture was used to extract the plasmids
using a Qiagen plasmid mini kit or midi kit.
3.4.2 NEBuilder HiFi DNA Assembly cloning Kit
This commercial kit allows to clone the DB sequence in a plasmid to test the in vivo
behaviour, it includes a 5’ exonuclease, a DNA polymerase and a DNA ligase, all working
in a one-pot reaction. All the experiments were performed following the manufacturer
recommendations.
The vector and the DNA fragments to be cloned must have overlapping ends of about
20 nt, the exonuclease digests the 5’ ends so the complementary sequences could anneal
in the right order. The polymerase extends the 3’ ends to rebuild the double helix and
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fFinally the DNA ligase seals the construct, that is ready to be transformed in a bacteria.
3.4.3 Colony PCR
Colony PCR protocol: the tip of a loop was dipped in the target colony and dissolved it
in 15 µl of water, the sample was heated to 95◦C for 5 minutes in a thermal block and
then centrifuged for 10 minutes at 13000 RCF. 2 µl of the supernatant were used as as
template.
Colony PCR was always performed using a Phusion PCR kit (NEB) following the
provided instructions.
3.4.4 E. coli T7 Express growth and induction protocol
2.4 kb insert E. coli T7 Express strains were streaked on agar plates with Kan and
incubated overnight at 37◦C in the shaker (shaking shelves in 37◦C room) .
A colony from each plate was inoculated in 1,5 ml of LB + Kan (50 µg/µl) and grew
overnight in the shaker.
In the morning each culture was refreshed in six tubes with 2 ml of LB + Kan (50 µg/µl),
three of them were induced with IPTG 0,5 mM and three left uninduced. All incubated
at 37◦C in the shaker.
981 nt insert The strains were streaked in agar plate with Kan and incubated overnight
at 37◦C. A single colony from each of them was inoculated in 1 ml LB + Kan (50 µg/µl)
and grew overnight at 37 ◦C in the shaker.
Each culture was refreshed in six tubes with 2 ml LB + Kan (50 µg/µl), three samples
uninduced and three samples induced with IPTG 50 mM.
3.4.5 Flow cytometry
The flow cytometry experiments were performed with a BD FACSCanto II, on modified
bacterial cultures to analyse the fluorescence generated by sfGFP expression systems. The
strains were streaked in agar plate with Kan and incubated overnight at 37◦C. A single
colony from each of the strains was inoculated in 1 ml LB + Kan (50 µg/µl) and grew
overnight at 37 ◦C in the shaker.
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Each culture was refreshed in six tubes with 2 ml LB + Kan (50 µg/µl), three samples
uninduced and three samples induced with IPTG 50 mM.
The fluorescence was analysed with a FACSCanto II cytometer after 4 and 6 hours of
growth at 37◦C in the shaker. For each sample, a 100 µl aliquote was taken and diluted
in 900 µl of PBS just before the analysis. The analysis was controlled manually and each
sample reached at least 35000 events.
3.5 Origami laboratory methods
3.5.1 pUC19 scaffold preparation
The pUC19 scaffold was generated through an enzymatic process. First, the plasmid was
nicked using the Nt.BspQI enzyme (NEB) that cleaves only one strand of the DNA double
stranded sequence. It recognizes only one sequence on pUC19 (position 690) and the cut
unravels the plasmid removing the supercoiled band from the agarose electrophoresis gel
[Fig. 4.2].
Once the plasmid was nicked it was digested with a mix of two nucleases: a T7 en-
donuclease (NEB) that can remove nucleotides from the nicked site, starting the reaction,
and a λ exonuclease (NEB), very efficient at removing nucleotides in a 5’-3’ direction, but
that cannot start from gaps or nicks. The nuclease reactions were performed following
the protocols provided by the producer and needed 20 hours to complete the digestion of
the anti-scaffold [Fig. 4.3].
3.5.2 DNA Origami folding protocol
Initially, the original origami folding protocol was favoured over the previous assembly
technologies for its simplicity. In detail, it was a one pot reaction, containing a long single
strand DNA scaffold and complementary staples in excess to 100 fold, isomolarity of the
oligonucleotides is not required. Ionic charges were added in the form of magnesium and
sodium salts, at variable concentrations depending on the design, to stabilize the negative
charges of the DNA backbone, their concentration was usually increased when folding 3D
origami to overcome the tight packing of the helices. The solution was then heated up to
95◦C to denaturate all the unwanted secondary structures. Finally a thermal ramp was
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applied to reduce the temperature at 20◦C in 2 hours [1].
pUC19 origami folding The origami folding was performed following the isothermal
protocol developed by Sobczak et al. [32].
A one-pot reaction is prepared mixing: TE buffer,Mg(OAC)2 [8 mM], NaCl [5mM],
origami staple mix [200nM]and DB 2.4 ssDNA scaffold [6 nM].
And an isothermal annealing is performed as follows:
a 95◦C 30 seconds denaturation, followed by a 51◦C 60 seconds isothermal annealing
and a final 4◦C hold
3.5.3 RNA/DNA hybrid origami folding protocol
DB Triangle origami folding The folding solution for the triangle origami is a classic
one-pot reaction. The base folding mix remained the same for all the experiments and it
is composed of TAE buffer 1X, Mg(OAC)2 [12.5 mM], Staple mix [100 nM] and DB Tri
RNA scaffold [10 nM].
R1 origami folding The R1 origami folding investigation was performed preparing a
mix of TAE buffer 1X, Mg(OAC)2 [12.5 mM], R1 staple mix [100 nM] and DB Triangle
short RNA scaffold [10 nM].
The origami was folded following an isothermal profile covering from 20◦C to 69◦C for
15 minutes, and holding the product at 4◦C at the end of the folding.
The folding products were loaded and run into 1.5% w/v agarose gel electrophoresis
in TAE buffer [Fig. 5.7].
DB square origami folding The R1 origami folding mix was composed of TAE buffer
1X, Mg(OAC)2 [12.5 mM], R1 staple mix [100 nM] and DB 981 RNA scaffold [10 nM].
The R1 origami 50X-staples folding mix was in practice the same reaction with a
higher staple concentration: TAE buffer 1X, Mg(OAC)2 [12.5 mM], R1 staple mix [500
nM] and DB 981 RNA scaffold [10 nM].
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3.5.4 Origami purification with Amicon Utra spin filters
500 µl of TAE buffer 1X were added to the column and centrifuged 5 minutes at 14000
rcf. The eluate was discarded. Folding buffer was added to the origami solution to 500 µl,
loaded in the column and centrifuged for 1 minute at 14000 rcf discarding the eluate. The
sample was washed three times ading 500 µl of folding buffer to the column and repeating
the centrifugation step. The sample was retrieved reversing the column in a new tube
and centrifuging it for 5 minutes at 1000 rcf.
3.5.5 Origami imaging
Transmission electron microscopy For TEM different protocols were tested chang-
ing reagent concentrations and incubations times. The most efficient experiment was the
one showed in [Fig. 5.3,3.2].
To prepare DB triangle for TEM, the copper grid was incubated with 5 µl of Mg(OAc)2
0.5 M for 1 minute, then it was dried with filter paper from the side, 5 µl of sample were
added and incubated for 4 minutes, the grid was dried again with filter paper, a 20µl drop
of uranyl formate 2% was put on parafilm and the grid was positioned on it, face towards
the liquid, for 40 seconds. The grid was dried one last time with filter paper and let it
dry in air for 5 minutes before loading it in the microscope probe.
Atomic force microscopy AFM protocol for DB triangle origami is a modified version
of the protocol used with DB 2.4 square. I found that nickel chloride forms a better ionic
bridge between the mica and the RNA origami than magnesium acetate or magnesium
chloride. It also works at much lower concentrations (10 mM against 125 mM of Mg++).
AFM protocol for DB triangle: the mica was cleaved for every new sample using
adhesive tape, 5 µl of the origami sample were added on the mica with 10 µl of NiCl2
10mM in TE buffer. NiCl2 10mM in TE buffer was used as scanning buffer for the fluid
cell.
3.5.6 Origami AFM imaging
DNA origami imaging [Fig. 4.6] was obtained with the following protocol:
a new mica sheet was cleaned using adhesive tape, 5 µl of Mg(OAc)2 125 mM was
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Figure 3.2: Transmission electron microscopy of the DB triangle origami. Full image of
[Fig. 5.3].
added to the surface with 5 µl of DNA origami sample. The imaging was performed in
magnesium buffer: TAE 1X, Mg(OAc)2 12.5 mM
DB R1 origami imaging For the imaging of DB R1 origami the mica was cleaved
before every sample, 20 µl of NiCl2 10 mM in H2O were added and incubated 3 minutes.
NiCl2 was removed using filter paper from the side of the mica to avoid contaminations,
then 20 µl of the origami sample was applied to the surface. Mg(OAc)2 12,5 mM in TAE
buffer was used as scanning buffer for the fluid cell.
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Figure 3.3: AFM image of the DB triangle origami. Full picture of [Fig. 5.4a].
3.6 In vivo DB scaffold study methods
3.6.1 PBAD33 reporter construct
pBAD33 was digested using HindIII-HF and KpnI-HF (NEB) restriction enzymes. An
agarose gel electrophoresis purification was performed on the digested vector, cutting the
gel band of interest and eluting the plasmid with a Monarch gel extraction kit (NEB).
The NEBuilder HiFi reaction mix was composed by HiFi buffer 1x, pBAD33-HindIII-
KpnI [0,1 pmol], DB 2.4 HiFi [0,2 pmol] and RBS-sfGFP HiFi [0,2 pmol]. The mix was
incubated at 50◦C for 30 minutes.
The new vector obtained, pBAD33-DB2.4-sfGFP [Fig. 3.4], was transformed in a E. coli-
5α competent strain (NEB) following the heat-shock transformation protocol included in
the kit: 2 µl of NEBuilder reaction were added to 50 µl of E. coli-5α competent cells
and mixed gently. The solution was put in ice for 30 minutes and the heat-shock was
performed at 42◦C for 30 seconds. The cells were put in ice for 2 minutes then 950 µl of
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SOC Outgrowth Medium (NEB) was added and the tube was incubated at 37◦C for 60
minutes shaking at 180 rpm. After the incubation 100 µl of the cells were spread onto an
agarose plate (Cam 25µg/µl) and incubated at 37◦C overnight.
Figure 3.4: Map of pBAD33-DB2.4-sfGFP.
The plasmid was finally extracted with a midi-prep kit (Qiagen) and sent for sequenc-
ing (MRC PPU DNA Sequencing and Services) using overlapping primers to increase the
precision.
pBAD33-DB2.4-sfGFP was also transformed in E. coli BL21 (DE3) and E. coli
MG1655 strains, to check the absence of arabinose-induced fluorescence at the micro-
scope (Nikon Eclipse Ti) (data not shown).
3.6.2 pET-28a reporter construct
pET-28a was digested with XbaI and HindIII restriction enzymes (NEB), an agarose gel
electrophoresis was performed to check the digestion [Fig. 3.5], and to purify the products
from the gel using a Qiaquick gel extraction kit (Qiagen).
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Figure 3.5: Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2
- pET-28a digestion with XbaI and HindIII, as backbone for Nebuilder HiFi reaction.
Low intensity fluorescence is due to a shorter EtBr staining step, to reduce the sample
exposure.
The digested vector was used with the Nebuilder HiFi kit in a one-pot reaction in-
cluding: HiFi buffer 1x, pET-28a-XbaI-HindIII [0,1 pmol], DB 2.4 HiFi [0,2 pmol] and
RBS-sfGFP HiFi [0,2 pmol].
The reaction was incubated at 50◦C for 60 minutes.
The final product was transformed into E. coli T7 Express competent cells (NEB), a
modified strain of E. coli BL21 expressing T7 polymerase.
3.7 Aptamers laboratory methods
3.7.1 Polyacrylamide gels
The aptamer folding experiments were analysed through polyacrylamide gel electrophore-
sis. All the gels used were polyacrylamide 10% in TBE from Invitrogen. The gels were
run at 200 V for 45 minutes. The staining of the gels varied depending on the aptamer
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analysed.
Broccoli aptamer The staining of the gel was composed of two separate steps, the
first for DFHBI-1T and the second for nucleic acids.
After the electrophoresis the gel was washed in RNase free H2O for 5 minutes, stained
for 30 minutes in DFHBI-1T staining solution and visualized using a Typhoon laser scan-
ner at 488 nm emission and 526 nm excitation.
The DFHBI-1T staining solution is composed of Hepes [40 mM], KCl [100 mM], MgCl2
[1 mM] and DFHBI-1T [10 µM].
The gels were washed three times in RNase free H2O for 5 minutes to remove the
staining and then incubated for 10 minutes in SYBR Gold nucleic acid gel stain (Thermo
Fisher) before visualizing it again with a Typhoon using the same wavelengths.
Malachite green aptamer The staining protocol is similar to the Broccoli experiments
and followed this procedure: a first wash in RNase free H2O for 5 minutes, stained for
30 minutes in MG staining solution and visualized in a Typhoon laser scanner using the
630 nm laser for the emission and 652 nm filter for the excitation. The Malachite green
staining solution was a mix of Hepes [40 mM], KCl [100 mM], MgCl2 [1 mM], Malachite
green [10 µM]
The gels were washed three times in RNase free H2O for 5 minutes to remove the stain-
ing and then incubated for 10 minutes in SYBR Gold nucleic acid gel staining (Thermo
Fisher) before scanning them again with a Typhoon, using SYBR Gold wavelengths (488
nm/526 nm).
3.7.2 Agarose gels
The aptamers-functionalized origami were analysed by agarose gel (1,5% W/V in 1X
TBE) electrophoresis and stained in a buffer composed of TAE 1X, MgCl2 [12,5 mM] and
Malachite green [5 µM] for 15 minutes.
3.8 Giant unilamellar vesicles methods
The protocol I used to generate the vesicles is a variant of the inverted micelle synthesis
[97] described in 2.2.6. It can be performed using a microplate, for smaller reaction
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volumes, or Eppendorf tubes for larger ones.
3.8.1 Labware silanization
The first step required is the silanization of the glassware and plasticware to avoid their
interaction with the lipids. Tubes, microplates and microscope slides are treated with
Repel-silane ES (GE Healthcare) as follow:
all the containers were filled with Repel-silane ES (or submerged in the case of micro-
scope slides) and incubated for 10 minutes, Repel-silane was removed and washed first
with ethanol and then water, repeating this passage three times, finally all the tools ere
dried under compressed air.
Silanization of microplates: Microplates wells were filled Repel-silane ES and incubated
for 10 minutes. Repel-silanewas removed and the wells were washed with water three
times. 100 µl of DNA from salmon sperm was added per well and incubated 10 minutes,
then washed with water three times and dried under compressed air.
3.8.2 Lipid mix preparation
The lipids used in the vesicle preparation were bought dried or in chloroform solution
(Avanti polar lipids). The final product was a 200 µM lipids solution in mineral oil,
formed by one or more lipid species.
Phospholipid solution protocol: the phospholipid powder was dissolved in chloroform to
5 or 10 mg/ml depending on the experiment. The lipids solutions were added accordingly
to the final volume and ratio, in a sealable vial. The chloroform was evaporated using
compressed air. Mineral oil was added to obtain a concentration of 200 µM. The vial was
sealed tightly and heated at 75◦C for 10 minutes in an oven or in a thermostatic bath,
it was then vortexed for 1 minute. The heating and vortexing steps were repeated three
times. The solution was then sonicated at 55◦C for at least 30 minutes and incubated
overnight at room temperature in a dark place to be used within three days.
It was noticed that sterile conditions improves the quality of the phospholipidic solu-
tion. It is also reported that air humidity contents over 50% could degrade the mineral
oil quality disrupting this application [107].
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3.8.3 Hosting and droplet solutions
The vesicle formation protocol requires the use of two aqueous solutions with different
densities, the hosting solution (HS), lighter, and the droplet solution (DS), heavier. At
the end of the vesicle preparation the HS is the extra-vesicular medium, while the DS
is the internal content of the vesicles. To avoid the bursting of the vesicles due to the
osmotic pressure, these two solutions must be equisomolar, within a tolerance range of
20 mOsm. Osmolarity was measured using a freezing point depression osmometer (Lser
Type 15 Auto). Glucose (molecular weight 180.156 g/mol) and sucrose (molecular weight
342.2965 g/mol) were added to the hosting and droplet solutions respectively to a final
osmolarity of 1000 mOsm, generating a large difference in density while producing a
minimal osmotic pressure.
The solutions can have different compositions, the DS could contain all the components
necessary to perform an experiment inside the vesicles, such as nucleic acids, fluorophores
and buffers.
3.8.4 Vesicles preparation
The preparation of the vesicles is composed of three steps [Fig. 3.6]. While the passages
are the same, the volumes changes if performed in microplates (M) or Eppendorf tubes
(E).
Preparation of the interface The host solution (HS) was vortexed and added to the
bottom of the vessel with a pipette (M 100 µl, E 500 µl) and spinned down in a centrifuge.
The phospholipid solution (PS) was votexed and added on top of the HS, pouring it slowly
from the side without touching the HS with the pipette (M 50 µl, E 200 µl). The mix
was incubated for at least 30 minutes until the two solutions formed a flat aqueous/lipid
interface.
Preparation of the inverted emulsion 6 µl of the droplet solution (DS) were added
to an Eppendorf tube, the cap was locked securely shear forceswere applied passing the
tube on the wells of a tube rack, repeating the movement 10 times or until the emulsion
was formed, finally the emulsion was vortexed for few seconds.
64 CHAPTER 3. EXPERIMENTAL AND COMPUTATIONAL METHODS
Figure 3.6: GUVs synthesis. A, B - Preparation of the interface. C - Inverted emulsion.
D - Preparation of the second interface. E - Formation of the vesicles.
Vesicles assembly The inverted emulsion was placed on top of the aqueous/lipid in-
terface pouring it slowly from the side of the vessel (M 100 µl, E 300 µl), the mix was
incubated for 5 minutes or until the inverted emulsion dropped completely onto the inter-
face. The samples were centrifugated 5 minutes at 500 RCF to generate a precipitate at
the bottom of the vessel, if the precipitate was not visible the centrifugation was repeated
at 1500 RCF to improve the yield. The mineral oil on top was removed with a vacuum
aspirator and 150 µl of HS were added.The centrifugation and the aspiration steps were
repeated to be sure that all the oil was removed. The vesicles were finally resuspended in
the host solution by gentle pipetting.
POPC preparation protocol The droplet solution (DS) was prepared with sucrose
[990 mM] and NaI [10 mM], the hosting solution (HS) with glucose [495 mM], sucrose [495
mM] and NaI [10 mM]. POPC was prepared dissolving the powder in chloroform to a final
concentration of 5 mg/ml and evaporating the chloroform leaving the tube open in the
fumehood. POPC was then dissolved in mineral oil to a final concentration 200 M. 100 µl
of HS were added in a microplate well.Slowly 50 µl of POPC solution was added on top
of the HS to form a layer, waiting for 30 minutes until the PS formed a flat interface with
HS. In a new Eppendorf the droplet emulsion was prepared adding 20 µl of DS in 1000
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µl of POPC and passing the tube on a tube rack surface 10 times to mechanically agitate
the content. 100 µl of emulsion were added on top of the HS-PS interface incubating the
sample 5 minutes to let the emulsion form a second flat interface.The vesicle reaction mix
was centrifuged at 1500 RCF for 3 minutes at 4◦C. The vesicles formation was checked
on an inverted microscope just on visible light to confirm the formation of the vesicles.
The top layer of the PS solution was removed using a vacuum pump. 150 µl of HS were
slowly added on top of the vesicles and centrifuged again to wash the sample removing
again the top layer of the solution.
A drop of 10 µl of vesicles solution was removed from the microplate well and put in
an observation chamber, in some of the samples a droplet of Nile Red was added on top of
the sample as phospholipidc bilayer staining dye. The observation chamber is formed by
a silanized microscope slide and a siliconized glass circle coverslide (Hampton research)
spaced by 1 mm handmade tape support and glued with transparent polish nail. The
sealed chamber prevents the evaporation of the vesicles droplet, allowing to reverse the
sample on the inverted microscope.
The vesicles were visualized using a Nikon Eclipse Ti inverted microscope. Brightfield,
GFP and Nile Red fluorescence.






In this chapter and in the next the results regarding the synthesis, folding and analysis of
the synthetic nucleic acid origami will be discussed. A fully synthetic, non-biological de-
rived nucleic acid sequence was folded into a complex nanostructure. The use of molecules
fully based on artificial designs has its advantages: allowing the selection of the desired
characteristics it is possible to overcome the natural limitations; at the same time the
research moves in ”uncharted territory” where no reference points are given because no
natural homologous exists.
4.1 DeBruijn sequence design
The De Bruijn sequence used for this experiment was designed by Dr. Kozyra with the
single purpose of folding a De Bruijn origami. The design of this sequence is based on the
necessity to compare a DB scaffold with a classic pUC19 scaffold 2686 nucleotides (nt)
long. In order to have a sequence this long, it was decided to have a minimal non-repeated
sequence of 6 nucleotides. Applying this number to the De Bruijn rule 4k it allows to have
a sequence long up to 46, or 4096 nt. As explained in chapter 3.2 the results were filtered
through different databases to remove the unwanted biological sequences like promoters,
terminators and the most common restriction enzymes. The theoretical bio-orthogonality
was then confirmed by an alignment analysis on BLAST. Once a set of possible sequences
was computed, a further optimization was performed using the ViennaRNA package. This
software allows the calculation of the minimum free energy (MFE) of DNA sequences and
the definition of the stability of secondary structures. A lower value for MFE means that
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the secondary structures are less stable, thus the annealing of the staples should happen
more easily. For the final sequence, 2484 nt long and with a GC content of 50%, a MFE of
-376.4 kcal/mol was measured, lower than -414.6 kcal/mol of pUC19 [2] [Tab. 4.1]. The
sequence was synthesized and cloned in a commercial plasmid by Life Technologies that
carries a kanamycin resistance cassette as described in 3.4.2.
Table 4.1: Sequence of the De Bruijn 2.4 Kb scaffold
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4.2 Scaffold preparation, origami folding and com-
parison
4.2.1 Origami design
To compare the two sequences a similar square origami was designed by Dr. Kozyra using
the CADnano software. The origami was folded by 70 staples that formed a squared shape
with a side of 50 nm [Fig. 4.1]. Depending on the ionic concentration the dimensions
can vary slightly, a high amount of positive charges relaxes the origami mesh, making it
larger. To adapt the longer pUC19 sequence to the same design, the 200 nucleotides in
excess were not folded and formed a dangling loop at the corner of the square.
TTTCT#ATGTCTGA#GCCTGAAA##ATGCGATA#TATCGTCA###GTCTCTGC#GGCTGCCG##AAACGCGC#TCAACCTC
T A C C G T G G # A A C C A C G G # # G A A A G G C A # A C C G A A C C # # # C T T T A A G G # C T A A T C G C # # G A G C C G G G # T C C C T A A G # A C A G C
GGGAT#TACCCGGG#CCGCGTCA##CGCAGTCC#TGTCTACT###AAGCCTAC#AGTGTAAA##GAGAGCCA#AGAGGTCT
C G T G T C A T # G G T C G C A C # # G C C T G G T T # G A G T C A G G # # # C T T A G A C T # C T T G C A T C # # C C C A G C A A # T A A G T A C A # T T G A C
GTGCC#GTTCACGT#ACGTTTCC##TGGACGCA#TGTGTGCG###TAAGGTCA#TAGAAGCC##GATCTCAC#CAAGCGCT
T A C A G A A G # A G C T G G C G # # A C A C G G A T # G G C G G T A T # # # A C C G A T A C # C C C C A T A T # # A A A G T T C G # T A T A A G G G # C A G G A
GTTAC#CTCGCGGT#TCGGTGGC##CGACGGCT#CACTGGAT###GTATAGTC#CCACTTCC##TCAGATGC#ACATCCTC
G A A G A C T T # C T G T T C G C # # A T T T T A G A # A A A C T A A C # # # A G C T C T C C # A G C C G C C C # # A A G T T A A A # A C G A C C C T # G T T T G
GTCAA#TGAAGGTG#GGAGTGCT##TGCCGCAG#GTAGCGAG###GTACACTT#ACGCCGGA##CCAAATCT#TTGGCCCG#
T G T A T G G A # T C A T C C A T # # A G C G C G A A # G T G A C A C A # # # C T G C C C C A # C C T C A T C T # # G A C T A C G G # T A A G T G C G # G A T T C
GGCAT#GGGGAACA#AAGCTCAT##TGGATAGC#TGAATAGC###CATACTGA#GGATAAAC##ACTAGGAA#TCGGGGGA
T A T C C G T G # A A G T T G A C # # C A T T A C G G # G C G C T A C C # # # A T G A C C G A # G G G A T G A C # # G A G A T T T A # G G C A C G T T # G T C C T
ACTTA#ACCCCTTG#CGGTCGGA##CTTTCGCG#TGCTCTAA###TGACTCGA#TTTGGGAT##CGTGGCGT#TGGTGTAG
A G C G T A T T # G G C A C T G T # # T G C A A T G T # G A A A T C G A # # # A C A T G G A G # A C G T T A G A # # T G A G T G T G # A T C C A C G T # G A G C T
TTGCA#GACAAAAC#AATGGTGA##TACTTCGT#TGCTCAGG###TGAGGCAT#AAGATGGT##ACTTGCTT#ATCGCAGC
C T T A A A G C # A G G G T C A G # # A G T C G G C T # T C A G A C C G # # # G A A A A A T T # C A A A A G C G # # A C T G T C G G # T T A T T C G C # T C G C A
ATTAT#CTCGCTTT#CACCTGTA##CCCAACAA#CGTATCTT###CCCCGATT#CACTTTAG##CCGTGCGA#CGCTTGTC
T G T G A G A C # C C G C G A T G # # G G C A A T C G # T A C C T A T A # # # A C A A G C C A # G A A A G A A G # # G C G G A C A T # A G T T A G G G # C G A A A
C G A T C # C C G G T G A C # C T A A C G G A # # G C T A C A T C # T A A G G A A G # # # C G T C C T T T # T G G A C T G A # # C G G A A T T A # G C T A T G A C
AATAGTAA#CCGGCTAT##TACACGAT#AGTGGTTA###AGAGTGAA#CACGCGAC##CGCGCCCG#AGTGGAGT#ACCAG
G C G C G # G C G A T T A A # G T C T A T T T # # A T G G T T T C # G A C T A T G C # # # T C G G C C C T # T A G G A C T A # # G C A T C T C T # C T T A T T T T
GCTAAATA#CAAGGGAG##ATCAGTGA#GTTGCCTC###TTCATAAA#TCACGAAG##GGGCATTG#CCCGGCAC#ACAGC
A T T A G # G T C C A G G A # C G A C A A G A # # A T C A G A A T # T G C G T C T A # # # A A A G T A A G # C A C G G C G G # # G T G T C G C T # A A C C T G A C
ATCGTTTT#CTGCTGAG##TAGAATAC#TCAGTATA###TACATAAT#GGCAAATG##AGCATATG#GGAAGGAT#GCGGG
G T A G T # C A C T A A A C # T T C A C A C C # # T A C G C A A A # G A T C G A C A # # # T G T T C A G T # T A T G C G T G # # T G T C C C G T # C G C G C G C A
TCGAGTTT#GCCAGGGA##ATAATCTG#TCAGCGTT###TGTGTACG#CGTTAACT##ATAGGTTC#AATTTCCG#TCTGT
A A G A A # A C A G A T A A # G C G G T G C A # # A G A C C T G G # C T T G G C T A # # # C G A G T A A T # C A T G A A A G # # T C G T A A T G # T C A A A T A G
AGTTCCTA#GGGACTCA##TGCCTAGC#CTCCCTGC###GAGACTAA#TACGATTG##TGACGCGG#GCTCGTCG#GGTTA
G C G G C # C A A C T T G G # A A G T A G T T # # G T G G C A T C # A G G G C C A C # # # A A A T T G A G # C G A T C G G T # # A G G A G C A A # G G A G A A C T
TTGTCTCA#GCTAAGTT##TCAGGATT#TTCCCTTC###CGAGAGAC#ACCCTCGG##TCACCGAC#TTATACGC#TGTCC
G G T T T # G A A T G T A C # T C T G A A C G # # T C T C C T T C # G C C A A A A T # # # C C G A A G C A # A A A A C C G C # # A A G T G T C T # T C G G A T A C
ACATACGT#GTTTCTTG##TTTTGTTA#CTATTCTC###AAAGTGGC#TGACCCAC##ACGTCATC#GGCGTCGT#GCATT
C C A A G # G T T A C G A A # C T A G A A C A # # G T C G C C T A # T G G C T C T G # # # G A A T G C A A # C A G G A A A C # # T C A C G G T T # G G G G C G G C
AGAGGCCC#ATGTCCAA##AGGGTGAA#TTTTTAAT###CCCTCACA#TTCTTCTT##TCTCTAGG#TAATAGGC#TGGGT
C G A A A # A G G T A T G C # A G T A G G T G # # T G G A T T G G # T T C T G G C A # # # G T T T T A T A # G A C A T T T G # # C G A A C G C C # C C C T G G G C
GATAACGC#TATCCTGC##ACTTGAGA#AATTAAAC###CAGCGAAT#CTATACTA##CTCGTAGC#AGATTGCT#GCGTT
G A G G T T G A # G C G C G T T T # # C G G C A G C C # G C A G A G A C # # # T G A C G A T A # T A T C G C A T # # T T T C A G G C # T C A G A C A T # A G A A A
GCTGT#CTTAGGGA#CCCGGCTC##GCGATTAG#CCTTAAAG###GGTTCGGT#TGCCTTTC##CCGTGGTT#CCACGGTA
TTTCG#CCCTAACT#ATGTCCGC##CTTCTTTC#TGGCTTGT###TATAGGTA#CGATTGCC##CATCGCGG#GTCTCACA
A G A C C T C T # T G G C T C T C # # T T T A C A C T # G T A G G C T T # # # A G T A G A C A # G G A C T G C G # # T G A C G C G G # C C C G G G T A # A T C C C
GTCAA#TGTACTTA#TTGCTGGG##GATGCAAG#AGTCTAAG###CCTGACTC#AACCAGGC##GTGCGACC#ATGACACG
A G C G C T T G # G T G A G A T C # # G G C T T C T A # T G A C C T T A # # # C G C A C A C A # T G C G T C C A # # G G A A A C G T # A C G T G A A C # G G C A C
TCCTG#CCCTTATA#CGAACTTT##ATATGGGG#GTATCGGT###ATACCGCC#ATCCGTGT##CGCCAGCT#CTTCTGTA
G A G G A T G T # G C A T C T G A # # G G A A G T G G # G A C T A T A C # # # A T C C A G T G # A G C C G T C G # # G C C A C C G A # A C C G C G A G # G T A A C
CAAAC#AGGGTCGT#TTTAACTT##GGGCGGCT#GGAGAGCT###GTTAGTTT#TCTAAAAT##GCGAACAG#AAGTCTTC
C G G G C C A A # A G A T T T G G # # T C C G G C G T # A A G T G T A C # # # C T C G C T A C # C T G C G G C A # # A G C A C T C C # C A C C T T C A # T T G A C
GAATC#CGCACTTA#CCGTAGTC##AGATGAGG#TGGGGCAG###TGTGTCAC#TTCGCGCT##ATGGATGA#TCCATACA
T C C C C C G A # T T C C T A G T # # G T T T A T C C # T C A G T A T G # # # G C T A T T C A # G C T A T C C A # # A T G A G C T T # T G T T C C C C # A T G C C
AGGAC#AACGTGCC#TAAATCTC##GTCATCCC#TCGGTCAT###GGTAGCGC#CCGTAATG##GTCAACTT#CACGGATA
C T A C A C C A # A C G C C A C G # # A T C C C A A A # T C G A G T C A # # # T T A G A G C A # C G C G A A A G # # T C C G A C C G # C A A G G G G T # T A A G T
AGCTC#ACGTGGAT#CACACTCA##TCTAACGT#CTCCATGT###TCGATTTC#ACATTGCA##ACAGTGCC#AATACGCT
G C T G C G A T # A A G C A A G T # # A C C A T C T T # A T G C C T C A # # # C C T G A G C A # A C G A A G T A # # T C A C C A T T # G T T T T G T C # T G C A A
TGCGA#GCGAATAA#CCGACAGT##CGCTTTTG#AATTTTTC###CGGTCTGA#AGCCGACT##CTGACCCT#GCTTTAAG
G A C A A G C G # T C G C A C G G # # C T A A A G T G # A A T C G G G G # # # A A G A T A C G # T T G T T G G G # # T A C A G G T G # A A A G C G A G # A T A A T
GTCATAGC#TAATTCCG##TCAGTCCA#AAAGGACG###CTTCCTTA#GATGTAGC##TCCGTTAG#GTCACCGG#GATCG
C T G G T # A C T C C A C T # C G G G C G C G # # G T C G C G T G # T T C A C T C T # # # T A A C C A C T # A T C G T G T A # # A T A G C C G G # T T A C T A T T
A A C G C # A G C A A T C T # G C T A C G A G # # T A G T A T A G # A T T C G C T G # # # G T T T A A T T # T C T C A A G T # # G C A G G A T A # G C G T T A T C
AAAATAAG#AGAGATGC##TAGTCCTA#AGGGCCGA###GCATAGTC#GAAACCAT##AAATAGAC#TTAATCGC#CGCGC
G C T G T # G T G C C G G G # C A A T G C C C # # C T T C G T G A # T T T A T G A A # # # G A G G C A A C # T C A C T G A T # # C T C C C T T G # T A T T T A G C
GTCAGGTT#AGCGACAC##CCGCCGTG#CTTACTTT###TAGACGCA#ATTCTGAT##TCTTGTCG#TCCTGGAC#CTAAT
C C C G C # A T C C T T C C # C A T A T G C T # # C A T T T G C C # A T T A T G T A # # # T A T A C T G A # G T A T T C T A # # C T C A G C A G # A A A A C G A T
TGCGCGCG#ACGGGACA##CACGCATA#ACTGAACA###TGTCGATC#TTTGCGTA##GGTGTGAA#GTTTAGTG#ACTAC
A C A G A # C G G A A A T T # G A A C C T A T # # A G T T A A C G # C G T A C A C A # # # A A C G C T G A # C A G A T T A T # # T C C C T G G C # A A A C T C G A
CTATTTGA#CATTACGA##CTTTCATG#ATTACTCG###TAGCCAAG#CCAGGTCT##TGCACCGC#TTATCTGT#TTCTT
T A A C C # C G A C G A G C # C C G C G T C A # # C A A T C G T A # T T A G T C T C # # # G C A G G G A G # G C T A G G C A # # T G A G T C C C # T A G G A A C T
AGTTCTCC#TTGCTCCT##ACCGATCG#CTCAATTT###GTGGCCCT#GATGCCAC##AACTACTT#CCAAGTTG#GCCGC
G G A C A # G C G T A T A A # G T C G G T G A # # C C G A G G G T # G T C T C T C G # # # G A A G G G A A # A A T C C T G A # # A A C T T A G C # T G A G A C A A
GTATCCGA#AGACACTT##GCGGTTTT#TGCTTCGG###ATTTTGGC#GAAGGAGA##CGTTCAGA#GTACATTC#AAACC
A A T G C # A C G A C G C C # G A T G A C G T # # G T G G G T C A # G C C A C T T T # # # G A G A A T A G # T A A C A A A A # # C A A G A A A C # A C G T A T G T
GCCGCCCC#AACCGTGA##GTTTCCTG#TTGCATTC###CAGAGCCA#TAGGCGAC##TGTTCTAG#TTCGTAAC#CTTGG
A C C C A # G C C T A T T A # C C T A G A G A # # A A G A A G A A # T G T G A G G G # # # A T T A A A A A # T T C A C C C T # # T T G G A C A T # G G G C C T C T
GCCCAGGG#GGCGTTCG##CAAATGTC#TATAAAAC###TGCCAGAA#CCAATCCA##CACCTACT#GCATACCT#TTTCG
Figure 4.1: Design and sequence of DB 2.4 square origami.
4.2.2 Scaffold preparation
Single strand DNA production A DNA origami scaffold is a single strand DNA (ss-
DNA) molecule. The sequences to compare were encoded in a double stranded plasmid.
Different strategies to remove the complementary strand were compared before charac-
terizing the most efficient protocol for each sequence. Being two different products, a full
plasmid in the case of pUC19 and an internal sequence for DB 2.4, two different techniques
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were applied.
Figure 4.2: Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2
- DB 2.4 digestion with λ exonuclease; lane 3 - pUC19 after nicking with Nt.BspQI;
lane 4 - pUC19 undigested. There are two clear bands on DB 2.4, the upper one is the
undigested dsDNA at 2400 nt, the lower one is the ssDNA scaffold around 900nt. The
nicking efficiency of Nt.BspQI enzyme is clearly showed in lane 3 where no supercoiled
pUC19 is detectable.
The preparation of DB 2.4 scaffold could not follow the standard pUC19 protocols
described in 3.5.1, and different strategies were tested to identify an efficient method. In
all the cases the first step required is a PCR (NEB Phusion) to amplify the DB sequence
and have it as a linear fragment. The first attempt followed Zhang et al. paper [4] and
involved the use of a phosphorylated reverse primer (IDT) at the 5’ end of the anti-
scaffold sequence. After the purification (Qiagen PCR purification kit), the PCR product
is digested with λ exonuclease. This exonuclease can digest only the phosphorylated
strand leaving the scaffold strand intact. Unfortunately, the reaction could not proceed
to completion for reasons unknown, even when the incubation time was increased over the
recommended time, probably because not all the primers were properly phosphorylated
[Fig. 4.2 and 4.3].
The second procedure I tested starts also from a PCR method published by Pound et
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Figure 4.3: Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2 - DB
2.4 digestion with λ exonuclease (higher starting amount, 4 hours long digestion); lane 3
- pUC19 after digestion from T7 endonuclease and λ exonuclease. It is clear, as in the
previous gel [Fig. 4.2] that DB 2.4 is not completely digested. On the other lane pUC19
is detectable as a single band at the 1 kb mark.
al. [3]. In this case the reverse primer is functionalized with a biotin (IDT functionalized
oligonucleotides). The biotinylated PCR product is then incubated with streptavidin-
coated magnetic beads. Once the DNA is attached to the beads a solution of NaOH is
added to denature the DNA. While the anti-scaffold remains attached to the beads, the
scaffold floats freely in the solution. The beads can be collected at the bottom of the tube
using a magnet and the scaffold solution is pipetted out to neutralize the pH in Na(OAc).
The first attempt was performed using NEB hydrophilic streptavidin magnetic beads and
a standard biotinylated primer. The yield of ssDNA was almost null. To improve the
efficiency I used a primer with a TEG-biotin modification where the biotin is connected
to the DNA 5’ end through a longer triethylene glycol linker that grants more space for
the biotin-streptavidin interaction [Fig. 4.4].
The performance of the system slightly increased, but not enough to produce an usable
amount of scaffold. A breakthrough was finally achieved using a different kit of magnetic
beads, the Dynabeads kilobaseBINDER kit (ThermoFisher scientific), coupled with TEG-
biotinylated primers.
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Figure 4.4: Structure of the biotin-TEG primer modification.
The DNA solution obtained was then purified by agarose gel electrophoresis to separate
the scaffold from the dsDNA residues and the band was extracted with a Freeze’n’squeeze
gel extraction kit (Bio-Rad) [Fig. 4.5]. This tailored protocol allowed the production of
a sufficient amount of scaffold necessary to perform the origami folding.
Table 4.2: Workflow for De Bruijn 2.4 Kb scaffold synthesis. This protocol allows the
production of a single DNA strand with an arbitrary sequence that can be used to fold a
DNA origami.
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4.2.3 Origami folding
The folding of DB 2.4 followed the same protocol as the control origami pUC19 2.4
described in 3.5.2.
To remove the staple excess the sample was brought to 500 µl with TE buffer 1X and
filtered through an Amicon Ultra centrifugal filter unit with a cutoff of 100 KDa at 14,000
RCF for 1 minute, repeating the washing step three times.
An aliquot was run on agarose gel electrophoresis (2% agar in TAE, ice bath cooled) for
an early confirmation of the origami formation [Fig. 4.5].
Figure 4.5: Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2 - DB
2.4 DNA origami folded; lane 3 - DB 2.4 ssDNA scaffold.
4.2.4 AFM imaging
A definitive confirmation of the origami folding was obtained with the help of atomic
force microscopy (AFM). I used a MultiMode 8 (Bruker) microscope in ScanAsyst mode
(automatic settings enabled) in liquid.
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As described in chapter 3.5.6, the sample was immobilized on a mica sheet using a
solution of positive ions.
(a) (b)
Figure 4.6: AFM of DB 2.4 and pUC19 DNA origami in detail, it is possible to discern
the formation of different origami structures. 4.6a - DB 2.4 DNA origami 4.6b - pUC19
DNA origami.
4.3 Summary
The results obtained from the comparison of the two origami shows clearly that the folding
efficiency of the DB 2.4 scaffold is comparable with the commonly used pUC19, the origami
are visible under the AFM microscope and the number of structures is comparable. It is
important to remark again about the synthetic nature of the sequence, the total absence
of encoded genes makes this technology a possible candidate for a future in vivo synthesis
and, in theory, for medical applications. Albeit the excellent folding results and the
theoretical bio-orthogonality given by the synthetic scaffold, this technology showed a
rather important flaw, the workflow to obtain the ssDNA is rather time-consuming and
expensive and it does not grant a large amount of final product per single reaction. A
possible solution could be the synthesis of ssDNA through rolling circle amplification [45].
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Figure 4.7: DB 2.4 DNA origami AFM panoramic scan (5 µm) of the final product. The
high number of well formed structures demonstrates the efficient yield of the tailored
protocols.
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Chapter 5
RNA/DNA hybrid origami
In this chapter I will discuss the experiments involving the use of an RNA DB scaffold
folded using DNA staples.
The use of RNA could be a viable option to prepare an origami in vivo. An RNA scaffold
can be easily synthesized through the most common biotechnological tools both inside and
outside the cell. RNA is a native single strand molecule, thus it is folding-ready. Moreover,
the efficiency of the in vitro synthesis is much higher than the ssDNA preparation showed
in chapter 4, making it a very good candidate for technological applications. The negative
side of using RNA is the susceptibility to RNases, the molecule is prone to degradation
as soon as the environment is not RNase free requiring extra care when working outside
of a PCR cabinet.
5.1 DeBruijn RNA sequence design
The De Bruijn sequence designed for the RNA/DNA hybrid origami is 1026 nt long. A
shorter scaffold was synthesized to make the folding less expensive, but long enough to
fold an origami easily recognizable under the microscope. The sequence is optimized to
the same degree of DB 2.4: the minimal non-repeated subsequence is 6 nt long and the
most common biological sequences are filtered out to be bio-orthogonal [2].
The first version of the sequence was inserted in a larger construct designed for the in
vivo transcription. It presents a T7 promoter followed by a LacO sequence at its 5’ to
have a strict control over the transcription. At the 3’ there is a T7 terminator. The first
origami designed uses only 981 nt of the whole sequence, leaving two shorts DB linkers
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at the edges. Because of the origami triangular shape, the sequence was named DB Tri
[Tab. 5.1].
Table 5.1: Sequence of the DNA template for DB Tri scaffold with legend.
Later, the template was modified to remove the unused parts, especially LacO and
T7 terminator, to improve the efficiency for the in vitro transcription, obtaining a new
sequence renamed DB 981 [Tab. 5.2].
Table 5.2: Sequence of the DNA template for DB 981 scaffold with legend.
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5.2 Origami triangle folding and analysis
Many combinations of origami design and laboratory techniques have been tested to obtain
the best results. I will separate this section in paragraphs, each of them will deal with a
different evolution of the scaffold and the origami.
5.2.1 DB triangle origami design
The first folding design is a hollow triangular shape formed by a sequence of three rectan-
gles forming the sides, each 30 nm long. The first and the last rectangles are connected by
two staples to close the origami in the right position [Fig. 5.1]. This origami is folded by
21 DNA staples and their sequences are optimized to reduce to a minimum the formation


























































































































































































































































































































































































































Figure 5.1: Design and sequence of the DB triangle origami. On the bottom left corner
it is possible to locate the two staples connecting the open vertex.
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5.2.2 DB Tri scaffold synthesis
The synthesis of the RNA scaffold started with the PCR amplification of its DNA template
(Phusion High-fidelity DNA polymerase NEB). The PCR product was purified (Qiagen
PCR purification kit) and used as the template for the RNA transcription (Ampliscribe
T7 Flash transcription kit).
The RNA product was purified again: during the triangle origami experiments I used
a phenol-chloroform-isoamyl alcohol mixture (Sigma-Aldrich) and ethanol precipitation
[Fig. 5.2], with the newer origami (square and rectangle) I adopted the faster Monarch
PCR and DNA cleanup kit (NEB), after assessing its good performances with RNA
molecules.
Figure 5.2: Agarose gel electrophoresis of: lane 1 - 50 bp DNA ladder (NEB); lane 7 -
DB Tri RNA scaffold purified with phenol-chloroform-isoamyl alchool; lane 8 - control
sequence.
5.2.3 DB Triangle origami folding
The investigation that led to the final folding protocol for the DB triangle has been
extremely long and involved dozens of different attempts. It can be divided into three
main parts:
1. Protocols based on the scaffold optimization theory: relying on the sequence opti-
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mization I tried to fold the origami with a short thermal ramp from 37◦C to 30◦C.
2. Protocols for co-transcriptional folding: in the attempt to simulate an in vivo folding
I prepared a one-pot reaction containing both T7 transcription and folding step
components.
3. Protocols based on the classic origami folding: this protocol includes a slow de-
scending thermal ramp from higher temperatures.
Protocols based on the scaffold optimization theory This protocol is the first
folding attempt using in vivo compatible conditions. The origami is heated up to 37◦C
without the first step of denaturation, then the temperature is slowly reduced to 30◦C
in the attempt to stabilize the structure. The lack of experience in origami folding and
microscopy techniques hindered the capacity to identify any definitive results. The only
image of TEM showing the triangle origami could not be replicated but, with the experi-
ence matured in these years, I can say that the origami formed showing the same design
limits of the subsequent attempts [Fig. 5.3]. Probably the difficulties encountered at the
microscope stemmed from the lack of a purification step after the folding, with the free
staples interfering with the sample deposition on the TEM grid.
Thermal profile: the sample was initially incubated at 37◦C for 5 minutes, a thermal
ramp of -0.01 ◦C/s was applied until the temperature of 30◦C was reached and held for 5
minutes, the final hold was at 4◦C.
Figure 5.3: Transmission electron microscopy of the DB triangle origami. In this enhanced
detail it is possible to see the nanostructure inside the black circle.
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Protocols for co-transcriptional folding In parallel to the previous protocol I tried
to prepare a more complicated process that unfortunately did not work. In this case, I
prepared a one-pot reaction including both the T7 transcription components and the sta-
ple mix. The addition of magnesium, for the nucleic acid folding, probably compromised
the activity of the T7 transcription. Even if this procedure did not work as expected, it
could be interesting to investigate its applicability for an optimized origami designed for
lower folding temperatures and ions concentration.
The transcription and folding mix was prepared as follows: T7 flash buffer 1X, nu-
cleotides [8 mM], DTT [10 mM], Riboguard RNase inhibitor 50 U, T7 polymerase (kit),
Mg(OAc)2 [12.5 mM], Staple mix 10 nM and DB Tri DNA template 250 ng. A thermal
annealing was applied starting at 42◦C for 30 minutes, appliying athermal ramp of -0.01
◦C/s to 30◦C and holding the sample at 4◦C.
Protocols based on the classic origami folding The last and most successful proto-
col can be described as a classic origami folding without denaturation step, in the attempt
to reduce the thermal ramp time, and staying in a temperature range compatible with
thermophile bacteria. The starting temperature is set to 65◦C that is more than enough
to remove any secondary structure or staple-staple interaction. The temperature is gradu-
ally lowered by 0.01 ◦C/s to allow the staples to anneal to the right scaffold domain, until
it reaches 25 ◦C. After the thermal folding, the origami is purified using a filter column
(Amicon centrifugal filter 100 KDa). The purified product is finally visualized through
microscopy [Fig. 5.4a and 3.3].
5.2.4 DB triangle origami results
The results obtained with the origami triangle showed a problem in the folding process. I
suspected that the incorrect folding of the two staples at the triangle vertex could cause
a high number of misfolded origami. This idea originates from the fact that it is possible
to identify a large amount of folded sides (rectangles) that are not closing into a triangle
shape. It is also possible to see linear structures longer than a single open triangle,
probably caused by the connection of two origami through the vertex staples [Fig. 3.3].
Another fundamental aspect of this origami, and all the RNA scaffolded structures, is
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(a) (b)
Figure 5.4: 5.4a - AFM image of the DB triangle origami. The quality of the image is
much clearer then TEM. 5.4b - An example of origami purification using Amicon Ultra
centrifugal filter: lane 3 - staples; lane 4 - R1 origami 10 µl; lane 5 - purified R1 origami
1 µl. The staples have been removed
the degradation of the sample when it is not handled in an RNase free environment.
Unfortunately, all the experiments were performed in facilities that are not designated as
RNase free, reducing the available time for the imaging before the samples degraded on
the microscope support.
5.3 DB square and DB rectangle origami folding and
analysis
Even if the results with the triangle origami showed that it is possible to fold a De Bruijn
RNA/DNA hybrid origami, we wanted to improve the technique in order to have a more
reliable platform for the future work. To address the misfolding problem Dr. Kozyra
designed a new origami based on the same scaffold.
The idea was to synthesize an origami that could be seen not only at the AFM but also
inside a cell or a vesicle. To do so the origami needs to carry a modification that can be
easily detected like a fluorescent molecule added to the staples.
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Two more design were tested in parallel, using the same DB Tri scaffold as in the triangle
origami. The first design is a square origami presenting linker staples on the perimeter
to allow the formation of a super-structure. The idea was to create an origami assembly
that would have been easier to see at the microscope. Also, a non-linked version of this
origami was designed to use as a control if the super-structure would not form.
The other new design is a rectangle that does not form links, the rectangle shape has
been chose because it makes it easier to identify the different sides of the structure.
In all cases, the staple sets were optimized to have a low minimum free energy to reduce
the formation of secondary structures as in the previous RNA origami.
5.3.1 DB square origami design
This is a very simple design, the scaffold is folded in a raster configuration and the resulting
square has a side of approximatively 30 nm.
In the assembly version there are 26 staples, of which six are linkers that are meant to
bind two domains in two different origami. When the origami are in position to form the
superstructure, the domains are adjacent and the linker staple can bind both of them.
The linked version also has longer intra-origami staples (not involved in the origami link)
that are binding three different domains forming two crossing-over.
In the non-linked version, the linker staples are separated in the two domains. Also the
three-domains binding staples are separated in two shorter ones to facilitate the folding,
bringing the staple number up to 31.
To perform the experiments two of the central staples were modified to carry a fluorophore
at their 5’, one with Alexa Fluor 488 (green) and the other with Alexa Fluor 594 (red).
All the staples were synthesized by Eurogentec.
5.3.2 DB rectangle 1 origami design
This origami is a standard rectangle (R1) with the scaffold arranged in a raster pattern
[Fig. 5.14]. Like the non-linked square, this design does not have any crucial staple that
could disrupt the whole structure if missing. The rectangle measures 35 nm by 25 nm
and is folded by 31 staples.
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5.3.3 R1 origami and DB square folding
Denaturation issue In the attempt to improve the origami synthesis workflow I ap-
plied the isothermal folding protocol described by Sobczak et al. [32]. This procedure
assures an effective folding of a 2D origami in less than 5 minutes when incubating it at
its exact folding temperature, after an initial denaturation. My idea was to reduce to a
minimum the time spent from the scaffold synthesis to the AFM imaging, so to increase
the quality of the results reducing the chances of RNase degradation.
To find the proper temperature for these origami I set up multiple folding reactions in
parallel following a thermal gradient. This experiment showed a peculiar scaffold be-
haviour that went unnoticed during the triangle folding: when the origami mix undergoes
a denaturing step of 75◦C or more, the resulting product will not move from the agarose
gel wells during the electrophoresis. This effect is probably caused by the formation of an
unpredicted agglomerate [Fig. 5.5].
Not being able to identify the problem at first, I tested all sort of protocol variations:
• all the isothermal folding temperatures from 20◦C to 72◦C
• classic thermal ramp protocol (a first denaturation and a slow temperature reduction
over a long time)
• scaffold modification removing the T7 terminator (renamed DB Tri short) suspecting
it could be part of some strong scaffold-scaffold interaction
• increasing the holding temperature after the folding up to room temperature (RT)
to disrupt any weak interaction
As a control, an unfolded origami mix left at room temperature was loaded on an
agarose gel electrophoresis [Fig. 5.6]. A band was visible at the 1 Kb mark, higher
than the scaffold band alone, indicating that some folding process was acting but without
forming the agglomerate that all the processed samples showed.
Origami folding Based on the effect shown by the control sample I repeated the process
for R1 origami removing the denaturation step to detect the best folding conditions.
Temperatures between 20◦C and 69◦C were tested in intervals of about 1.3◦C.
A smaller experiment was also performed with the linked square origami testing the
new protocol at 20◦C, 39◦C and 54◦C following the same protocol [Fig. 5.8].
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Figure 5.5: Agarose gel electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane 2 - DB
Tri RNA scaffold; lane 3 - R1 staple mix; lane 4 to 6 - R1 origami folding at 20◦C - 37◦C
- 54◦C post denaturation. It is possible to detect a strong signal on the lower edge of the
origami wells.
DB981 R1 folding Before solving the denaturation problem the shortened version of
the scaffold was ordered, named DB 981, suspecting the issue could be related to one of
the regulating components. As previously described, this sequence lacks the LacO, T7
terminator and DB linkers surrounding the 981 nt used in the triangle folding. As one can
notice the R1 origami is designed to cover a sequence including both the linkers (1026nt),
this means that the first and last staples in R1 only bind one domain each, while the
other acts as overhang.
The scaffold preparation proved to be more efficient, especially when amplifying the DNA
template. Moreover, this is a true DB sequence without biological components [Fig. 5.9a].
The folding of the R1 origami was always performed with the isothermal short protocol
without denaturation. Three temperatures were tested: 37◦C for the in vivo possibility,
50◦C and 55◦C to check the temperatures around the theoretical optimal area [Fig. 5.9a,
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Figure 5.6: Agarose gel electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane 2 - DB
Tri RNA scaffold; lane 3 - R1 staple mix; lane 4 - R1 origami mix at RT; lane 5 to 16
- R1 origami folding from 22◦C (5) to 38◦C (16) post denaturation. The lane 4 band is
higher than the scaffold in lane 2 suggesting an origami folding process.
5.9b].
After the folding, the samples were purified with Amicon Ultra centrifugal filters 100
KDa and visualized under the microscope.
A modified version of R1 folding was tested to investigate the effect of a 50:1 ratio of
staples and scaffold to see if it could improve the yield.
I compared the isothermal folding at 55◦C with the classic denaturation/thermal ramp
protocol [Fig. 5.10].
The isothermal origami was also purified using Amicon Ultra centrifugal filters 100
KDa before imaging it at the AFM.
5.3.4 DB R1 origami imaging
The origami visualization at the AFM was performed improving the protocol used for
the triangle origami. In this new version, the nickel chloride drop is added first to form
the ionic bridges. After a brief incubation, it is removed with filter paper to reduce the
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Figure 5.7: Agarose gel electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane 2 - DB
Tri RNA scaffold; lane 3 - R1 staple mix; lane 4 - R1 origami mix at RT; lane 5 to 16 -
R1 origami folding from 53◦C (5) to 69◦C (16) post denaturation. In this agarose gel it is
possible to see that the bands of the origami folded from 53◦C (lane 5) to 64◦C (lane 12)
are clean and much higher than the control incubated at RT (lane 4). It is also possible
to see how the origami starts to melt at temparatures higher than 65◦C (lane 13).
background noise that is probably caused by the formation of nickel salt crystals. Also,
nickel chloride is dissolved in water instead of TAE buffer to avoid chelation through
EDTA. Finally, the AFM in scanning buffer used is the origami folding buffer instead of
nickel chloride buffer.
It was clear from the AFM analysis that the only working protocol was the one with
the folding set at 55◦C. Nor 37◦C or 50◦C foldings formed any origami [Fig. 5.11, 5.12].
Folding the origami using the high staple ratio drastically increased the origami yield,
but at the same time increased the background signal probably due to staple residues left
over from the purification [Fig. 5.13].
5.3.5 DB R1 origami results
When using an isothermal folding with an incubation up to 15 minutes, R1 RNA/DNA
hybrid origami correctly folds at 55◦C, at the lower tested temperatures the folding is
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Figure 5.8: Agarose gel electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane 2 - DB
Tri RNA scaffold; lane 3 - square basic staple mix; lane 4 - square fluorescent staple mix;
lane 5 - square linker staple mix; lane 6 - 20◦C folding; lane 7 - 39◦C folding; lane 8 -
54◦C folding. As with R1 the higher band is located around 55◦C.
partial or absent.
A higher staples concentration helps the folding increasing the yield of well-formed origami.
A peculiar behavior of all the RNA DB origami mix is detected after the denaturation
step: an unknown assembly is formed and its physical properties do not allow it to run
through an agarose gel.
5.4 Summary
These experiments demonstrate that it is possible to use a synthetic De Bruijn RNA
scaffold to properly fold a hybrid RNA/DNA origami.
The results from this set of experiments confirmed Kopielski’s paper [33] performed on
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(a) (b)
Figure 5.9: 5.9a - Agarose gel electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane
2 - DB 981 R1 origami 37◦C folding; lane 3 - DB981 DNA template. 5.9b - Agarose gel
electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane 2 - DB 981 R1 origami 50◦C
folding, purified; lane3 - DB 981 R1 origami 55◦C folding, purified; lane 4 - DB981 RNA
scaffold.
phagic DNA origami. The optimizations obtained by the full sequence design proved
efficient as expected, allowing the origami isothermal folding and producing a good yield
of nanostructures. DB R1 origami also showed a predisposition for the folding at lower
temperatures, even if it this feature was not designed on purpose. These findings are
very promising in perspective of the in vivo folding, an aimed refinement of the scaf-
fold sequence could probably allow a complete synthesis at life-compatible temperatures
for the most part of the microorganisms. In the long term vision, a synthetic scaffold
has a greater potential granted by the optimization capabilities without sacrificing any
molecular characteristic.
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Figure 5.10: Agarose gel electrophoresis of: lane 1 - 1Kb DNA ladder (NEB); lane 2 -
DB 981 RNA scaffold; lane 3 - R1 origami 50X staples isothermal 55◦C folding; lane 4 -
R1 origami 50X staples classic denaturation/thermal ramp folding. While the isothermal
folding shows an origami band (lane 3), the classic folding forms the agglomerate in the
gel well (lane 4).
(a) (b)
Figure 5.11: 5.11a - R1 origami 37◦C folding shows only traces of unfolded scaffold; 5.11b
- R1 origami 50◦C folding shows a series of misfolded or partially folded origami.
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Figure 5.12: R1 origami 55◦C folding shows a good number of well formed rectangular
origami, on the right is visible an origami probably broken by the AFM probe contact.
(a) (b)
Figure 5.13: R1 origami 55◦C folding using a 50:1 = staple:scaffold ratio. The folding
efficiency is very high, a large amount of origami is visible; 5.13a - a panoramic scan with
higher definition. 5.13b - a zoomed-in image with lower definition. Increasing the zoom
means that the probe spends more time over a single object, the ScanAsyst system uses
a lower strength on the Z-axis to reduce the chances of interaction between the probe
and the substrate, reducing at the same time the definition of the image. This effect is
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Chapter 6
In vivo DB scaffold study
The design of a DB synthetic scaffold relies on the key concepts of bio-compatibility
and bio-orthogonality. In this chapter, I describe the experiments performed in vivo to
characterize the impact that these sequences have on the cell transcription and translation
systems. I designed a series of genetic constructs that could measure the impact of DB
sequences (2.4 and 981) when inserted between the promoter and the ribosome binding
site (RBS) of the superfolder Green Fluorescent Protein (sfGFP) gene. I compared the
results obtained with these sequences with controls replacing each DB sequence with a
section of E. coli polymerase gene dnaE of the same length. dnaE was selected for its
dimension, allowing the selection and amplification of an internal sequence that does not
contain known promoters or terminators, it was also chosen for being an E. coli gene, a
common bacteria easily found in many microbiology stocks.
sfGFP is an engineered fluorescent protein encoded by a 714 nt long gene. It is a more
robust version of the natural GFP and it conserves the same excitation (488 nm) and
emission (530 nm) wavelengths [108].
The protocol for creating these constructs is generated using the NEBuilder Assembly
tool, the online software that designs the proper primers for the NEBuilder HiFi DNA kit
reaction (http://nebuilder.neb.com/). The kit allows the building of a genetic construct
in a one-pot reaction containing all the linearized sequences that will compose the final
plasmid.
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6.1 pBAD33 based construct
The first attempt to create an expression system to analyse the effect of a DB sequence
involved the use of pBAD33 plasmid as a backbone for the construct.
pBAD33 is a common cloning expression vector for E. coli, it contains a chloramphenicol
(Cam) resistance cassette and the arabinose PBAD promoter [109].
6.1.1 De Bruijn 2.4 reporter gene construct
In order to clone DB 2.4 and RBS-sfGFP into pBAD33 vector using NEBuilder HiFi
DNA Assembly master mix (NEB) I followed the suggested kit protocol:
DB 2.4 and RBS-sfGFP were amplified with a PCR reaction (Q5 PCR kit NEB)
DB 2.4 primers for HiFi reaction in pBAD33:
• DB 2.4 fwd: AGCGAATTCGAGCTCGGTACCTTTCTATGTCTGAGCCTG
• DB 2.4 rev: CTCTTTAATTTTTCGCCCTAACTATGTC
RBS-sfGFP primers for HiFi reaction in pBAD33:
• (RBS)-sfGFP fwd: TAGGGCGAAAAATT(AAAGAGGAGAAA)CCTAG
• sfGFP rev: CTCATCCGCCAAAACAGCCAAGCTTTATTATTTGTAGAGCT-
CATCC
The PCR products were cleaned using Monarch DNA purification kit (NEB) before
the final assembly.
6.1.2 pBAD33-DB2.4-sfGFP expression
To test E. coli-5α with pBAD33-DB2.4-sfGFP six cultures were prepared, each in 2 ml
LB + Cam 25µg/µl. Three were induced with arabinose 0.02% at the inoculation and
three were left uninduced as control. After 5 hours The samples were analysed in the flow
cytometer (Partec CyFlow space) to check the sfGFP fluorescence. The cytometer was
controlled manually and all the samples reached at least 50000 events. The results showed
that the induction had almost no effect [Fig. 6.1], meaning that the DB 2.4 completely
disrupts the activity of PBAD promoter.
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Suspecting that the non-coding DB sequence could have been the cause of a short
processivity of the RNA polymerase, decoupling itself from the template before reaching
the gene, the construct was cloned on a different plasmid.
6.2 pET-28a based constructs
pET-28a is an expression vector that is designed to work in a T7 RNA polymerase expres-
sion system. The relevant components of this plasmid are the T7lac promoter inducible
with IPTG and the kanamycin (Kan) resistance cassette.
DB, dnaE and RBS-sfGFP sequences were cloned using the NEBuilder HiFi kit.
As for the previous experiment the primers were designed using the online NEBuilder
assembly tool.
6.2.1 De Bruijn 2.4 reporter gene construct
DB 2.4 and RBS-sfGFP inserts were amplified with Q5 PCR (NEB):
DB 2.4 primers for HiFi reaction in pET-28a:
• DB 2.4 fwd: GAGCGGATAACAATTCCCCTCTAGATTTCTATGTCTGAGCCTG
• DB 2.4 rev: CTCTTTAATTTTTCGCCCTAACTATGTC
RBS-sfGFP primers for HiFi reaction in pET-28a:
• (RBS)-sfGFP fwd: TAGGGCGAAAAATT(AAAGAGGAGAAA)CCTAG
• sfGFP rev: GGTGCTCGAGTGCGGCCGCAAGCTTTTTATTATTTGTAGAGCT-
CATCC
The components where assembled using the NEBuilder HiFi kit into pET-28a and
transformed in E. coli T7 Express competent cells.
14 colonies of E. coli T7 Express were selected and inoculated in LB + Kan (50 µg/µl)
to check for the presence of the right construct. The plasmids from each culture were
extracted using a Miniprep plasmid extraction kit (Qiagen) and digested with XbaI and
HindIII to cut out the insert and check if the dimensions were compatible with the desired
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sequences [Fig. 6.2 ].
Plasmids from colony 14, the only plasmid of the right size, all the other plasmids
presented a smaller size with an insert compatible with RBS-sfGFP sequence only.
Plasmid 13 and 14 were sent for sequencing (MRC PPU DNA Sequencing and Services)
confirming the agarose gel electrophoresis findings.
Plasmid 14 became pET-28a-DB 2.4-sfGFP [Fig. 6.3].
Plasmid 13 was kept as positive control and renamed pET-28a-sfGFP [Fig. 6.4].
The cultures containing the plasmids where finally conserved in stocks at -80◦C.
6.2.2 dnaE 2.4 reporter gene construct
As a control sequence to compare with DB 2.4 I choose a fragment of E. coliMG1655 dnaE
DNA polymerase III subunit alpha gene. This gene was chosen for its ready availability
and its dimensions: being 3483 nt long it allowed to choose an internal sequence large
as DB 2.4 excluding all the known bioactive sequences as promoters or terminators. The
gene was conveniently amplified from a chromosomal DNA stock of our lab using a Q5
PCR kit.
dnaE primers for chromosome PCR (Eurogentec):
• dnaE 2.4 forward: CCGCACCGTTGGTAAAAAAG
• dnaE 2.4 reverse: CTTCGATGATGGCCTCAATC
The NEBuilder HiFi reaction was designed to add the dnaE product on the pET-28a-
sfGFP control plasmid [Fig. 6.5]. The vector was digested with XbaI (NEB).
Primers for dnaE 2.4 NEBuilder reaction (Eurogentec):
• dnaE 2.4 HiFi forward: GAGCGGATAACAATTCCCCTCTAGACCGCACCGTTG-
GTAAAAAAG
• dnaE 2.4 HiFi reverse: TCAGGCTCAGACATAGAAATCTAGACTTCGATGATG-
GCCTCAATC
All the components were purified using Monarch DNA purification kit before setting
up the NEBuilder HiFi reaction mix.
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• HiFi buffer 1x
• pET-28a-XbaI-(RBS)sfGFP 0,1 pmol
• dnaE2.4 HiFi 0,2 pmol
The mix was incubated at 50◦C for 60 minutes.
The plasmid obtained was transformed in E. coli T7 Express, and checked with a
colony PCR [Fig. 6.6].
The two colonies presenting the proper insert were sent for sequencing for the final
confirmation. As for the other samples the colonies were stocked at -80◦C.
6.2.3 De Bruijn 2.4 and dnaE 2.4 in vivo expression
The comparison of the different constructs was performed in parallel and involved:
• E. coli T7 Express pET-28a-DB 2.4-sfGFP
• E. coli T7 Express pET-28a-dnaE 2.4-sfGFP
• E. coli T7 Express pET-28a-sfGFP
The cultures were analysed with flow cytometry after 4 hours and 7 hours from the
induction, using the cytometer (Partec CyFlow space) and analysing 50000 events for
each culture [Fig. 6.7].
The stand-alone sfGFP has the best expression overall. Unexpectedly, it is clear from
the analysis that the vector carrying the DB 2.4 sequence is the one with the worst
efficiency. dnaE 2.4 is placed halfway, clearly reducing sfGFP expression, although not
to the same extent as the DB sequence.
6.2.4 De Bruijn 981 and dnaE 981 reporter gene constructs
To further investigate the bio-orthogonality characteristics I also compared DB 981 with
a 981 nt fragment of dnaE [Fig. 6.8 and 6.9].
This time the protocol used for the synthesis of the two constructs was the same.
pET-28a-sfGFP was digested with XbaI (NEB) and purified with Monarch DNA purifi-
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cation kit.
The two sequences for the cloning were amplified using a Q5 PCR kit (NEB).
Primers for DB 981 HiFi (Eurogentec):
• DB 981 HiFi forward: GAGCGGATAACAATTCCCCTCTAGAGCGGTCCAGC-
TAGCAGGT
• DB 981 HiFi reverse: TCAGGCTCAGACATAGAAATCTAGACTGTACTGCGAC-
GACCTAAATCG
Primers for dnaE 981 HiFi (Eurogentec):
• dnaE 981 HiFi forward: GAGCGGATAACAATTCCCCTCTAGAGATTTCAC-
CAACCTTTGTGGTCTG
• dnaE 981 HiFi reverse: TCAGGCTCAGACATAGAAATCTAGACAGTGAACC-
CGCACCGGA
Both the inserts were purified with Monarch DNA kit.
The NEBuilder HiFi kit was used as suggested by its protocol:
• HiFi buffer 1x
• pET-28a-XbaI-(RBS)sfGFP 0,1 pmol
• 981 nt insert HiFi 0,2 pmol
Both incubated at 50◦C for 60 minutes. The new vectors were transformed in E. coli
T7 express competent strains (NEB).
As for the other vectors, the correct synthesis was confirmed by colony PCR [Fig.
6.10] and sequencing of the chosen colony (MRC PPU DNA Sequencing and Services)
after Miniprep extraction (Qiagen).
The strains containing the sequenced vectors were stocked at -80◦C.
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Primers for pET-28a colony PCR:
• pET28 forward: CTATAGGGGAATTGTGAGCGG
• pET28 reverse: CCCTCAAGACCCGTTTAGAGG
6.2.5 De Bruijn 981 and dnaE 981 in vivo expression
The same experimental procedures performed for DB 2.4 sequences were used to compare
the strains containing the 981 nt samples.
• E. coli T7 Express pET-28a-DB 981-sfGFP
• E. coli T7 Express pET-28a-dnaE 981-sfGFP
• E. coli T7 Express pET-28a-sfGFP
The fluorescence was analysed with a FACSCanto II cytometer after 4 and 6 hours
of growth at 37◦C in the shaker. The analysis was controlled manually and each sample
reached at least 35000 events.
This analysis shows that sfGFP alone is always the most efficient construct, but this
time the DB 981 has a slightly better protein expression than the dnaE 981 control
sequence [Fig. 6.11].
6.2.6 Summary
The in vivo experiments described in this chapter tried to assess the bio-orthogonality
of the De Bruijn sequences I used as origami scaffolds. These experiments analysed the
impact of the DB sequences in the transcription efficiency of a gene cloned at their 3’.
Obviously, the conclusions that can be inferred by the data collected are limited to the
transcription-translation process that happens on the vector transformed.
The first important conclusion is the necessity for a T7 RNA polymerase mediated tran-
scription to produce a non-coding synthetic sequence. The use of the native transcription
system was not functional, probably because the RNA polymerase loses its processivity
when the target sequence does not interact with the translation machinery: this could
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happen to save resources, because the bacteria does not transcribe a sequence that will not
be translated. A T7 polymerase system could facilitate a tight control over the produc-
tion, controlling the polymerase expression through an induction system, but on the other
hand, it requires the use of dedicated strains as E. coli T7 Express. It also demonstrates
that the non-coding DB sequence does not show any transcription activating feature.
As expected both the vectors with an additional cloned sequence have a lower efficiency
compared to sfGFP alone. The transcriptional burden is more than doubled with the
981 nt long sequences and almost four-fold higher with the 2.4 knt ones.
The data shows also how the two DB sequences behave differently compared to the con-
trols. The larger DB 2.4 shows a higher negative impact on the final expression of sfGFP,
while the protein synthesis when the shorter DB 981 is present, is much closer to the
control strain. The causes for this behavior are not clear, as the database analysis does
not find any match with other known sequences, they can only be hypothesized. It could
depend on the activity of secondary structures due to the peculiar thermodynamic design,
or on the presence of an unknown regulatory factor encoded in the sequence itself.
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(a) (b)
Figure 6.2: 6.2a - Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB);
lane 2 to 14 - plasmid extracted from colonies 1 to 13 digested with HindIII; lane 15 -
plasmid extracted from colony 14 digested with XbaI and HindIII . 6.2b - Agarose gel
electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2 to 6 - plasmid extracted from
colonies 9 to 13 digested with XbaI and HindIII; lane 7 - plasmid extracted from colony
14 linearized with HindIII; lane 8 - pET-28a double digestion with XbaI and HindIII as
control.
Figure 6.3: pET-28a-DB 2.4-sfGFP map.
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Figure 6.4: pET-28a-sfGFP map.
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Figure 6.5: pET-28a-dnaE 2.4-sfGFP map.
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Figure 6.6: Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2 -
dnaE 2.4 control; lane 3 to 8 - dnaE 2.4 colony PCR from pET-28a-dnaE 2.4-sfGFP
transformants. It is possible to see a band at control level only in lanes 6 and 7.
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Figure 6.8: pET-28a-DB981-sfGFP Map.
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Figure 6.9: pET-28a-dnaE 981-sfGFP Map.
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Figure 6.10: Agarose gel electrophoresis of: lane 1 - 1 Kb DNA ladder (NEB); lane 2 to
5 - pET-28a-DB 981-sfGFP PCR ; lane 6 to 8 - pET-28a-dnaE 981-sfGFP PCR colony
PCR. PCR in lane 7 is faulty for the lack of template. All the colonies tested showed a
correct PCR product.




















































































































This chapter is focused on the synthetic biology prototype toolset designed to study
origami folding. These devices demonstrate nucleic acid origami and giant unilamellar
vesicles technologies working in synergy. As vesicles can be used as protocells, they can
provide part of the in vivo conditions avoiding the drawbacks of uncontrolled factors. Vesi-
cles content can also be characterized through fluorescence analysis using high-throughput
instruments. These capabilities can allow the detection and quantification of the folding
of a functionalized origami. The origami staples are modified so they generate a signal
upon the correct annealing on the scaffold. Different staples solutions were analysed to
achieve a good folding detection, investigating different fluorescent aptamers and fluo-
rophores. The origami folding reporter tool is not strictly bound to the vesicles system
and can also be used in the classic in vitro experiments. The aim of these experiments
was the creation of two tools that allow understanding better the origami folding process.
In their simplest version, the origami components are inserted inside the vesicles allowing
to follow the folding process using a fluorescence effect.
7.1 DB origami fluorescent reporters
The analysis of the origami folding requires a system that allows discriminating between
a folded origami and an unfolded one.
To solve this problem I investigated the feasibility of different fluorescence complexes im-
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plemented on the RNA/DNA hybrid R1 origami described in chapter 5.3.2. The concept
behind this experiment is the use of the staples as folding reporters, when the marked
staples are correctly annealed on the origami scaffold, they will interact emitting a signal.
I tested three different systems:
• Broccoli aptamer [110]
• Malachite Green aptamer [66]
• Cy-3/Cy-5 FRET effect
7.1.1 Broccoli aptamer
The broccoli aptamer is an RNA sequence, derived from the Spinach aptamer, that forms
an hairpin-like secondary structure. This structure is capable of binding a DFHBI-1T
fluorescent molecule, considerably increasing its emission. The broccoli aptamer has been
tested in vitro and in vivo. One of the most interesting applications is the use of a




Broccoli split 1: GUAUGUGGGAGACGGUCGGGUCCAGAUA
Broccoli split 2: UAUCUGUCGAGUAGAGUGUGGGCUCCCACAUAC
When the two oligos are annealed to a common substrate, the two halves of the ap-
tamer are adjacent and will reconstitute the aptamer activity. The experiment design
started with the selection of three couples of staples to use as connectors for the aptamers
halves. The first half extended from the 3’ of one staple and the second from the 5’ of the
staple next to it. The couples selected were (aptamer sequence in brackets):
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(a) (b)
Figure 7.1: 7.1a - Broccoli aptamer can bind the molecule DHFBI-1 and stabilize it in its
fluorescent state. 7.1b Broccoli structure at 25◦C.
Staple 17 and 30
staple 17: GUUUAACCCACCGAGUCCUAUCACUUGUACCC (GUAUGUGGGAGACG-
GUCGGGUCCAGAUA)
staple 30: (UAUCUGUCGAGUAGAGUGUGGGCUCCCACAUAC) AACACAACAGCU-
CUUC
Staple 14 and 27
staple 14: ACGAAGCCUGACUGUGAUUCAGCGUAAAAACUCG (GUAUGUGGGA-
GACGGUCGGGUCCAGAUA)
staple 27: (UAUCUGUCGAGUAGAGUGUGGGCUCCCACAUAC) CGAUCUCGAGAACUGUC-
CGGUGCGAUAUUACUAU
Staple 4 and 6
staple 4: GAGUGAUCGUUGCUAUCGAGCUAUUUCAAGCCCG (GUAUGUGGGA-
GACGGUCGGGUCCAGAUA)
staple 6: (UAUCUGUCGAGUAGAGUGUGGGCUCCCACAUAC) UGGAAGCUGUACUGCG
To space apart the signals I chose one staple couple from the 5’ of the portion of the
scaffold (17-30), one from the 3’(4-6) and one from the middle portion (14-27)[Fig.7.2].
For this experiment, only the aptamer staples were synthesized as RNA, all the other
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Figure 7.2: The split Broccoli aptamers location on R1 origami is marked with red circles.
The Broccoli aptamer is split in two halves, each half is added as a staple extension
on two consecutive staples protruding from the origami surface one next to the other.
This configuration allows the regeneration of the functional aptamer structures when the
origami is properly folded. Aptamers: ”17-30” top-left circle; ”4-6” bottom-left circle;
”14-27” centre-right circle.
origami staples were the same DNA oligos from the original design.
First, the modified staples were tested in a simpler assembly, using a target sequence
complementary to the two staples domains to check the correct aptamer reconstitution.
In these experiments, I mixed the three strands in a one-pot reaction following an origami
isothermal folding protocol.
Broccoli aptamer regeneration protocol: the reaction is composed of: modified staple
1 [500 nM], modified staple 2 [500 nM], target sequence [500 nM], Hepes [10 mM], KCl
[100 mM] and MgCl2 [1mM].
The thermal folding is a single step at 55◦C for 15 minutes and a hold step at 4◦C
The samples were loaded on a polyacrylamide gel.
The results show how all the couples regenerate the aptamer when the target sequence is
added, but also that couples 14-27 and 4-6 regenerate it without the connector sequence
in the control experiment [Fig. 7.3 and 7.4].
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Figure 7.3: Polyacrylamide gel electrophoresis of: lane 1 - LMW DNA ladder (NEB);
lane 2 - staple 17; lane 3 - staple 30; lane 4 - 17-30 target; lane 5 - staples 17-30 and
target; lane 6 - staples 17-30 no target. 7.3a Gel after DFHBI staining. 7.3b Same gel
after SYBR gold staining.
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(a)
(b)
Figure 7.4: Polyacrylamide gel electrophoresis of: lane 1 - LMW DNA ladder (NEB); lane
2 - staple 14; lane 3 - staple 27; lane 4 - 14-27 target; lane 5 - staples 14-27 and target;
lane 6 - staples 14-27 no target; lane 7 - staple 4; lane 8 - staple 6; lane 9 - 4-6 target;
lane 10 - staples 4-6 and target; lane 11 - staples 4-6 no target . 7.4a Gel after DFHBI
staining. 7.4b Same gel after SYBR gold staining.
To understand why the aptamers form also without target sequences, I analysed the
staple combinations using the NUPACK software (http://www.nupack.org/). The anal-
ysis confirms that the aptamer structure is the most stable conformation that the oligos
can assume when reacting in two or more copies [Fig. 7.5]. The analysis was performed
considering only a maximum of four interacting oligos to reduce the computational time.
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(a)
(b)
Figure 7.5: 7.5a - Staples 14-27 interaction. 7.5b - Staples 4-6 interaction. NUPACK
analysis of two couples of oligonucleotides composing the Broccoli aptamer used in the
experiments. In both cases the thermodynamic properties of the sequences used regenerate
the aptamer even without the help of a target strand (or the origami scaffold). The
aptamer structure is recognizable on the right on fig. 7.5a and on the left on fig. 7.5b
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As the couple 17-30 showed an expected behavior, I performed an origami folding test,
substituting the original 17-30 staples with the version carrying the aptamer parts. The
electrophoresis result shows again the formation of multiple active aptamers at different
band levels [Fig. 7.6]. Probably the presence of the other 29 staples generates a favorable
condition for the aptamer formation.
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Figure 7.6: Polyacrylamide gel electrophoresis of: lane 1 - LMW DNA ladder (NEB); lane
2 - 1 Kb DNA ladder (NEB); lane 3 - DB 1026 RNA scaffold; lane 4 - staple mix; lane 5
- DB 1026 R1 origami with Broccoli aptamer. 7.6a Gel after DFHBI staining. 7.6b Same
gel after SYBR gold staining. A multiple aptamer formation is visible in both staple (lane
4) and origami (lane 5) lanes.
For the purpose of this experiment the thermodynamical optimization of the origami
staples plays unfavorably. The staples, as a matter of fact, are designed to avoid the
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formation of secondary structures and they find stability in the hairpin stems generated
by the aptamer nucleotides. To overcome this problem I designed a new set of split
broccoli aptamer staples, with a shorter hairpin stem with a lower stability.
7.1.2 Short broccoli aptamer
Using the NUPACK software I analysed a new design for the split Broccoli aptamer
staples that has a shorter hairpin stem, removing 8 nt (Bros - Broccoli short), reducing
the chances of the aptamer regeneration in the absence of the scaffold sequence. Testing
the new aptamer on NUPACK for all the origami staple couples, only the couples 17-30
Bros and 24-20 Bros showed a behaviour compatible with the experiment. It is important
to notice that the staples 24 and 20 are not in line but parallel, their 3’ and 5’ respectively
are lying on a crossover spot, and so they are oriented in the same direction, increasing
the chances of having the aptamer split sequences on the same face of the origami [Fig.
7.7].
Figure 7.7: The shorter Broccoli aptamers location on R1 origami marked with red circles.
This is another split Broccoli aptamer design, where each half of the aptamer is added
as a staple extension on two consecutive staples protruding from the origami surface one
next to the other. On the right cirlce is the 24-20 couple, the two halves are located on
two different scaffold strands, at a cross-over point, coming out on the same side of the
origami.
The new staples were tested following the same folding protocol as in the first design.
Unfortunately, the couple 24-20 Bros showed no aptamer regeneration while the couple
17-30 Bros showed fluorescence as in the longer design [Fig. 7.8a].
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Figure 7.8: Polyacrylamide gel electrophoresis of: lane 1 - LMW DNA ladder (NEB); lane
2 - staple 17 Bros; lane 3 - staple 30 Bros; lane 4 - target sequence for staples 17-30; lane
5 - 17-30 Bros; lane 6 - 17-30 Bros and target sequence; lane 7 - staple 24 Bros; lane 8 -
staple 20 Bros; lane 9 - target sequence for staples 24-20; lane 10 - 24-20 Bros and target
sequence. 7.8a Gel after DFHBI staining. 7.8b Same gel after SYBR gold staining. Only
the staples 17-30 Bros show DFHBI-1T fluorescence (lane6).
A pilot experiment was then performed using a plate reader to identify any difference
between a folded origami and an unfolded one. Theoretically, there should be a high
difference in fluorescence between the samples. Unfortunately, the thermodynamics op-
timization of the origami design, combined with the high laboratory temperatures and
the lack of cooling system in the plate reader, compromised the experiment: the unfolded
control origami began the folding process before the analysis was completion, showing no
difference in the fluorescence output against the folded samples (data not shown).
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7.1.3 Malachite green aptamer
The second design for the folding reporter uses the malachite green (MG) split aptamer
and was tested in parallel to the short Broccoli aptamer as an alternative option.
Malachite green sequence: UUUCCCGACUGGCCAGGUAACGAAUGGAUU
Malachite green split 1: UUUCCCGACUGG
Malachite green split 2: CCAGGUAACGAAUGGAUU
The NUPACK analysis was also performed on all the potential modified couples of
the R1 origami to avoid the formation of unwanted secondary structures. MG aptamer
is much smaller and with a lower stability still only the 4-6 couple simulation worked
properly and was chosen in addition to 17-30 and 24-20 [Fig. 7.9].
The staple sequences are (aptamer sequence in brackets):
Staple 17 and 30
staple 17 MG: GUUUAACCCACCGAGUCCUAUCACUUGUACCC (UUUCCCGACUGG)
staple 30 MG: (CCAGGUAACGAAUGGAUU) AACACAACAGCUCUUC
Staple 14 and 27
staple 24 MG: AGCUGGACCGCCACGA (UUUCCCGACUGG)
staple 20 MG: (CCAGGUAACGAAUGGAUU) UCACAGAACCGUGCGCCGCGGGGC-
CCCGUUUGUG
Staple 4 and 6
staple 4 MG: GAGUGAUCGUUGCUAUCGAGCUAUUUCAAGCCCG (UUUCCCGACUGG)
staple 6 MG: (CCAGGUAACGAAUGGAUU) UGGAAGCUGUACUGCG
The folding experiments using the target sequence were performed in the same aptamer
buffer used with Broccoli.
The Malachite green aptamer regeneration protocol was composed of: modified staple
1 [500 nM], modified staple 2 500 [nM], target sequence [500 nM], Hepes [10 mM], KCl
[100 mM] and MgCl2 [1mM]. The oligos were annealed following a thermal folding at 55
◦C
for 15 minutes, and holding the sample at 4◦C
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Figure 7.9: MG staples location on R1 origami marked with red circles. The split Mala-
chite green aptamer halves are added as extensions on two adjacent staples allowing the
regeneration of the full aptamer when the origami is correctly folded. 17-30 top-left circle;
4-6 bottom-left circle; 24-20 top-centre circle.
The samples were analysed in a 10% polyacrylamide gel in TBE.
The results show that the only staples not able to regenerate a functional aptamer are
17-30 MG, while 24-20 MG and 4-6 MG generate a strong fluorescence [Fig. 7.10].
All the MG staple couples were tested also in the origami folding, alone and in combi-
nation. The origami were folded using the isothermal protocol at 55◦C for 15 minutes as
for the other R1 origami, Using a staple mix concentration 10-fold higher than the scaf-
fold. The samples were analysed through AGE and the MG gel staining was performed
in folding buffer.
The results show that the strongest aptamer on the origami is the couple 4-6 MG,
but at the same time it can reconstitute a functional aptamer just interacting with some
other staple. Surprisingly the couple 17-30 works properly but shows a lower fluorescence.
Finally, the couple 24-20 shows the weakest fluorescence of all [Fig. 7.11].
Another plate reader pilot experiment was performed to check the difference between a
folded origami reporter and its unfolded control, the results showed again how the DB
sequence optimization facilitates the origami folding at room temperature activating the
aptamer signal [Fig. 7.12].
7.1.4 FRET
The last option developed for the construction of an origami-folding reporter take advan-
tage of FRET effect. Two staples are functionalized with Cy-3 and Cy-5 modifications,
when the staples are annealed to the right scaffold domain, the fluoroscopes are close to
each other and the FRET interaction happens. When Cy-3 is excited with a 532 nm laser
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(b)
Figure 7.10: Polyacrylamide gel electrophoresis of: lane 1 - LMW DNA ladder (NEB);
lane 2 - staple 17 MG; lane 3 - staple 30 MG; lane 4 - target sequence for staples 17-30;
lane 5 - 17-30 MG; lane 6 - 17-30 MG and target sequence; lane 7 - staple 24 MG; lane 8 -
staple 20 MG; lane 9 - target sequence for staples 24-20; lane 10 - empty; lane 11 - 24-20
MG; lane 12 - 24-20 MG and target sequence; lane 13 - staple 4 MG; lane 14 - staple 6
MG; lane 15 - target sequence for staples 4-6; lane 16 - 4-6 MG; lane 17 - 4-6 MG and
target sequence; lane 18 - LMW DNA ladder (NEB). 7.10a Gel after MG staining. 7.10b
Same gel after SYBR gold staining. Staples 24-20 MG (lane 12) and 4-6 MG (lane 17)
can regenerate the aptamer, while staples 17-30 MG (lane 6) are not working.
it emits a fluorescence at 568 nm, this emission is sufficient to excite Cy-5 that will emit
in turn at 666 nm. When the staples are not in the proper position the effect should be
much lower or absent, exciting Cy-3 will not activate Cy-5. I based this experiment on
the paper published by Niederholtmeyer et al. [111], where the two FRET fluorophores
are positioned at 5 nt distance from each other. Considering that the functionalization
can be added at a 5’ or 3’ end of the oligo, or internally on a thymine nucleotide, in the
R1 origami only two staple couples are compliant with these parameters [Fig. 7.13].
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Figure 7.11: Polyacrylamide gel electrophoresis of: lane 1 - LMW DNA ladder (NEB);
lane 2 - DB R1 origami; lane 3 - DB R1 origami 17-30 MG; lane 4 - DB R1 origami 24-20
MG; lane 5 - DB R1 origami 4-6 MG; lane 6 - DB R1 origami all MG staples . 7.11a Gel
after MG staining. 7.11b Same gel after SYBR gold staining. Mg fluorescence is weak
with 17-30 MG staples (lane3), almost absent with 24-20 MG (lane 4) and very strong
with 4-6 MG (lane 5). Unfortunately, 4-6 MG generates a strong fluorescence also in the
staple mix, indicating a non-specific aptamer regeneration.
Figure 7.12: Mix of DB 1026 R1 origami after plate reader analysis. All the control
samples started the folding process due to the high temperatures forming bands close to
the origami sample.
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Staple 13 and 3 FRET
staple 13 Cy-3: ACGCTAGAGAC(T-Cy3)CCGT
staple 3 Cy-5: Cy5-TCTGGTAGTCGAAAACATGTGCGTCTAAGTGCGG
Staple 26 and 25 FRET
staple 26 Cy-3: GTTCTAATTCT(T-Cy3)GAATCTCCAGACTTTTGGGC
staple 25 Cy-5: CY5-TATAACAATAGTTACCCAGAAATTAGAATTTCGA
Figure 7.13: FRET staples location on R1 origami marked with red circles. The marked
staples are modified to carry Cy3 and Cy5 fluorophores, when the origami is correctly
folded they will interact with a FRET effect. 13-3 top-right circle; 26-25 centre-left circle.
These staples were tested directly in the origami folding. As the first experiments
showed a quite strong background due to the ten-fold excess of staples over the scaffold
(data not showed), it was decided to use an isomolar concentration of fluorescent staples
and scaffold.
Th DB R1 FRET origami folding was performed in a one-pot reaction containing: TAE
1X, MgCl2 [12,5 mM], R1 origami staples mix (without fluorescent staples) [200 nM], DB
981 scaffold [20 nM], 13-3 staples [20 nM] and 26-25 staples [20 nM]. The isothermal
folding was performed at 55◦C for 15 minutes and the sample was held at 4◦C.
The folded origami were analysed through AGE 1% W/V in TBE. The results show a
clear FRET effect from staples 13-3 and a weak one from staples 26-25 when exciting the
sample for Cy3 and detecting Cy5 fluorescence, meaning that the staples are in FRET
range when the origami is correctly folded. Staple 25 Cy-5 does not seem to anneal the
scaffold with a very high efficiency, reducing the origami fluorescence and increasing the
background signal. The origami carrying all the fluorescent staples has a signal output
compatible with the sum of the two other samples 7.14.
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(a) (b) (c) (d)
Figure 7.14: AGE of: lane 1 - 1 Kb DNA ladder (NEB); lane 2 - R1 with 13-3 FRET;
lane 3 - R1 with 26-25 FRET; lane 4 - R1 with 13-3-26-25 FRET; lane 5 - R1 origami;
lane 6 - RT origami mix. 7.14b - SYBR Gold staining. 7.14b - Cy-3/Cy-5 FRET. 7.14c
Cy-3 filter. 7.14d Cy-5 filter.
To further confirm these findings I performed a plate reader analysis comparing the
different staple combinations, unfortunately, also in this case, the origami optimization
allowed the folding of the control samples. Nonetheless this time a sensible difference in
fluorescence was measured [Tab. 7.1].
13-3 FRET 26-25 FRET All FRET Ctrl
Fold 45797 (dev 3961) 35200 (dev 3344) 81415 (dev 3774) 4636
Unfold 28647 (dev 5129) 24804 (dev 7650) 42733 (dev 10969)
Table 7.1: Plate reader experiment on R1 origami using FRET staples. In brackets the
standard deviation. Ctrl refers to R1 origami folded without fluorescent staples.
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7.2 Vesicles synthesis
7.2.1 Preliminary experiments
Artificial giant unilamellar vesicles (GUV) are phospholipidic liposomes that simulate a
double layer cell membrane. I decided to use these vesicles as a carrier for the origami
folding experiment. They allow replicating some of the cellular conditions and are used in
origin of life studies. The protocol I use to synthesize them is derived from the inverted
emulsion technique developed by Pautot et al. in 2003 [97]. The protocol as been slightly
modified and adapted by Prof. Hanczyc from the University of Trento.
Using this protocol I managed to synthesize GUVs loaded with GFP for their visualization
[Fig. 7.15]. I also generated vesicles loaded with a folded origami solution.
Figure 7.15: Giant unilamellar vesicles preliminary test, stained with nile red and visual-
ized using a Nikon Eclipse Ti inverted microscope.
7.2.2 Giant unilamellar vesicles synthesis
In my experiments I synthesized GUVs using three different kinds of phospholipids: 1-
palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC, Avanti polar lipids) alone or in com-
bination with the negatively charged 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] (PEG2000 PE, Avanti polar lipids) or the positively
charged 1,2-dioleoyl-3-trimethylammonium-propane (chloride salt) (DOTAP, Avanti po-
lar lipids).
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The first vesicles synthesis experiment, to familiarize with the technique, followed the
general protocol described in section 3.8. The vesicles were produced with a solution of
pure POPC. The formation was confirmed by microscopy.
The droplet solution (DS) was prepared with sucrose [990 mM] and NaI [10 mM],
the hosting solution (HS) with glucose [495 mM], sucrose [495 mM] and NaI [10 mM].
POPC was prepared dissolving the powder in chloroform to a final concentration of 5
mg/ml and evaporating the chloroform leaving the tube open in the fumehood. POPC
was then dissolved in mineral oil to a final concentration 200 M. 100 µl of HS were added
in a microplate well.Slowly 50 µl of POPC solution was added on top of the HS to form
a layer, waiting for 30 minutes until the PS formed a flat interface with HS. In a new
Eppendorf the droplet emulsion was prepared adding 20 µl of DS in 1000 µl of POPC and
passing the tube on a tube rack surface 10 times to mechanically agitate the content. 100
µl of emulsion were added on top of the HS-PS interface incubating the sample 5 minutes
to let the emulsion form a second flat interface.The vesicle reaction mix was centrifuged
at 1500 RCF for 3 minutes at 4◦C. The vesicles formation was checked on an inverted
microscope just on visible light to confirm the formation of the vesicles. The top layer of
the PS solution was removed using a vacuum pump. 150 µl of HS were slowly added on
top of the vesicles and centrifuged again to wash the sample removing again the top layer
of the solution.
A drop of 10 µl of vesicles solution was removed from the microplate well and put in
an observation chamber, in some of the samples a droplet of Nile Red was added on top of
the sample as phospholipidc bilayer staining dye. The observation chamber is formed by
a silanized microscope slide and a siliconized glass circle coverslide (Hampton research)
spaced by 1 mm handmade tape support and glued with transparent polish nail. The
sealed chamber prevents the evaporation of the vesicles droplet, allowing to reverse the
sample on the inverted microscope.
The vesicles were visualized using a Nikon Eclipse Ti inverted microscope. Brightfield,
GFP and Nile Red fluorescence confirmed the formation of the giant unilamellar vesicles
[Fig. 7.15, 7.16].
Another experiment was performed to test the vesicles synthesis in Eppendorf tubes
and with differently charged phospholipid mixes:
• POPC
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(a)
(b)
Figure 7.16: Inverted microscope imaging of GUVs. 7.16a - Brightfield imaging of a high
concentration spot to notice the high yield of GUVs synthesis. 7.16b - GFP imaging of
GUVs of different sizes.
• POPC + PEG2000 PE (25:75 and 50:50 ratios)
• POPC + DOTAP (25:75, 50:50, 60:40, 40:60 and 75:25 ratios)
While the standard POPC behaved as expected, the most interesting results were
obtained using the negatively charged POPC-PEG2000 PE mixes, capable of forming
more resistant vesicles and higher yields, a side effect is that these vesicles fissate in smaller
liposomes over time and cannot fuse with positively charged vesicles as the PEG2000
chains prevent the interactions. The POPC-PEG2000 vesicles were also generated using
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an R1 origami solution as DS.
The vesicles containing DOTAP did not form when loaded with DNA, maybe because of
the interaction between the positively charged lipids and the negatively charged nucleic
acid was not favorable to the formation of lipoplexes [112].
7.3 Summary
7.3.1 Origami-folding reporter
The preliminary experiments on the origami-folding analysis tool highlighted a series of
critical issues that can be used to better understand the nature of nucleic acid origami
and how to apply this powerful technology.
The results described in section 7.1.4 show that R1 origami starts to fold at very low
temperatures. Even if it is a non-complete process, it is sufficient to partially anneal
the staples on the scaffold, activating the FRET effect between the fluorophores. This is
clearly due to the scaffold and staples optimization of the RNA/DNA hybrid designs: the
single components ca not form strong secondary structures providing any thermal barrier
to the folding process.
The very same effect is also the cause of the split Broccoli aptamer regeneration described
in section 7.1.1: the presence of the aptamer hairpin stem facilitates the formation of staple
polymers, even in the absence of the scaffold. It is the opposite result of the experiment
described by Afonin et al. [66], where the assembly folding regenerates the aptamer.
Almost paradoxically, the over-optimization of a parameter (the folding) becomes sub-
optimal in the optic of a new goal.
On the other end the Malachite green split aptamer is not very stable in the origami buffer
and its fluorescence is extremely weak, for this reason it was discarded from the options.
Moreover, the staples carrying the aptamer splits are RNA oligonucleotides more prone
to degradation and more expensive to synthesize.
The project based on the FRET effect is the more promising for future applications. It
works with DNA staples and it does not add any extra nucleic acid sequence. The limit I
applied to the design, 5 nt distance between the fluorophores, can be loosened increasing
the possibilities for multiple signals on a single origami. Based on the experimental
results I also decided to discard the 26-25 FRET couple, keeping the 13-3 FRET staples
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as reporter for the fluorescence experiments.
A nucleic acid origami is a highly technological machine, it requires a fine tuning calibrated
on the task to perform, but at the same time its design can be optimized just by changing
the set of staples, keeping the scaffold, the shape and any other characteristic unchanged.
7.3.2 Giant unilamellar vesicles
The experiments performed on the GUV synthesis, even if at a primordial state, do not
show any concerning aspect. The vesicles formation allows the insertion of the origami,
and few more experiments could confirm the feasibility of the folding analysis. More
advanced experiments could involve the study of the origami folding inside a proto-cell at






The objective of my research project was to characterise the application of synthetic nu-
cleic acid sequences as origami scaffolds. The hypothesis underlying this idea is that the in
vivo synthesis of nucleic acid nanorobots will dramatically increase their biotechnological
value, transforming these niche-technologies into powerful reprogrammable (and possibly
reprogramming) biological machines. To better explain this statement it is necessary to
define some of the features characterizing nucleic acid origami.
The definition of nanorobots, as nanometric automata performing a work, has been widely
demonstrated by many applications. Origami can be used for their structural properties,
like boxes, pores, struts or gears; they can be functionalized and used as nanoarrays,
cheaper than classic microarrays; origami can also be programmed to respond to a stim-
ulus, taking advantage of strand displacement techniques or the origami folding itself.
Origami are reprogrammable because a single scaffold can be used to fold different struc-
tures using different sets of staples, these features makes the scaffold reusable, it also
opens up to possible applications where the origami structure changes depending on the
environment.
Finally, the most biotechnological aspect of all, the origami can be ”reprogramming”.
The activity of a nucleic acid origami inside a cell could change the behavior of its host,
simpler assemblies have been introduced in vivo with good results, an origami can only
expand these capabilities providing a control system expressed and folded by the cell it-
self.
The scaffold sequences here designed are based on combinatorial rules described by a
Dutch mathematician, Nicolaas Govert de Bruijn. A nucleic acid De Bruijn (DB) se-
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quence is formed by nucleotide subsequences of predetermined length that occur only
once even for different reading frames, this means that every domain composing a DB
origami scaffold can be unique by design.
Being arbitrarily designed, a synthetic sequence of this type can present many advantages
over a natural one, in our case we wanted to obtain three main features:
• unique addressability
• bio-orthogonality
• origami folding optimization
The unique addressability is the direct effect of the DB algorithm, setting the subse-
quences length at 6 nt, every staple domain (8 or 16 nt) has at least two mismatching
nucleotides if binding the wrong staple: in the case of competitive annealing, during the
strand displacement phase, the correct staple will always have at least two stable nu-
cleotides.
The bio-orthogonality, optimized in E. coli, was obtained cutting away all the biological
sequences recorded in the most common genetic databases, avoiding the presence of pos-
itive and negative transcription factors and recurrent restriction enzymes.
The origami folding optimization was performed analysing the minimum free energy of
the sequences obtained and choosing the one with the lower result. The scaffold obtained
presents weaker secondary structures that could hinder the correct staple annealing even
at lower temperatures. The unique addressability of the scaffold also contributes to the
folding optimization, always favoring the annealing of the correct staples to the proper
scaffold domain.
Two DB sequences were used as DNA and RNA origami scaffolds and some aspects of
their bio-orthogonality were characterized inside E. coli.
Finally, I designed an application consisting of a functionalized origami designed to work
inside phospholipidic giant unilamellar vesicles.
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8.1 De Bruijn scaffold validation
8.1.1 DB 2.4 DNA origami
The DNA sequence designed using the De Bruijn algorithm folded the origami with a good
yield, comparable, if not superior, to pUC19 control. Nonetheless, this scaffold presented
a major challenge during the DNA single strand synthesis steps.
Two different protocols were tested to obtain an amount of scaffold sufficient to fold an
origami batch.
The first protocol involving the digestion of the phosphorylated complementary strand
proved completely inefficient. Even if a small part of the starting product was transformed
in ssDNA, it was not sufficient to retrieve it after the necessary purification steps. Nor
increasing the enzyme concentration or incubation time made a difference. The causes of
this failure are not clear, but it is probably due to an imperfect phosphorylation of the
amplification primers that caused only a partial digestion of the complementary strand,
resulting in a very low yield of DNA scaffold.
The second protocol was instead based on the biotinylation of the complementary strand
and its capture through streptavidin-coated magnetic beads. This protocol granted the
synthesis of the necessary amount of ssDNA scaffold but still required micrograms of
starting dsDNA. In terms of efficiency, although sufficient for the required experiments,
this protocol is clearly not compatible with a future scale-up. It must be noted that, in
the last years, new ssDNA synthesis protocols have been created, in particular the use
of rolling circle amplification that allowed the in vitro production of grams of origami
scaffold.
The origami folding procedure performed well, granting a good product yield, especially
considering that it was the first time a DB origami was folded using an isothermal protocol.
This experiment was also important as a testbed for AFM microscopy techniques, being
DNA more stable than RNA, it allowed performing more extensive tests for longer times
without degrading.
8.1.2 DB RNA/DNA hybrid origami
The study of RNA scaffold/DNA staples hybrid origami explored further after the first
folding, generating a greater feedback in terms of DB sequences insight and origami fold-
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ing. The issues tackled during this process involved the design, folding and imaging of
the origami.
DB triangle The research on DB triangle hybrid origami mainly focused on the opti-
mization of basic steps such as synthesis, folding and imaging processes.
The T7 RNA polymerase transcription solved the problem presented by the ssDNA scaf-
fold, a single T7 reaction produces an amount of RNA scaffold in the order of micrograms
and the required purification can be reduced to a single spin-column step, this method is
clearly compatible with the hypothetical scaling-up required for industrial applicability.
On the other hand, working with RNA requires extra care to avoid its degradation. Ri-
bonucleases are ubiquitous and the slightest contamination could degrade the sample,
especially when working at folding temperatures (i.e. 40-60◦C). Performing the experi-
ments under a PCR cabinet solved the problem during the synthesis phase, but the lack
of an RNase-free microscopy facility translated in an increased number of experiments
to set-up the visualization protocols and reduced the final quality of the results. The
only way to mitigate this problem consisted of the accurate cleaning of the instruments
when possible. These precautions allowed the recording of AFM and TEM images. The
microscopy analysis showed a better performance of AFM over TEM, electing the former
as the main visualization technique.
Different folding protocols were tested for this origami: an attempt of cotranscriptional
folding resulted in the absence of scaffold, probably related to the excess of ions in so-
lution that blocked the T7 RNA polymerase, this path was not investigated further to
focus on more rapid solutions; the classic folding consisting in a descending thermal ramp,
derived from the original origami paper, performed sufficiently well allowing the origami
formation. The DB triangle origami predates all the other origami experiments therefore
no isothermal folding was tested on this design.
The final results on the DB triangle origami highlighted a flaw in the design that causes
a misfolding of the vertex between the 5’ and 3’ scaffold ends: with the two locking sta-
ples not being stable enough, probably for the large distance between the domains, the
only functional solution consisted in a different origami design that would not rely on an
unpredictable locking system. A more classic rectangular design was produced to confirm
the synthetic RNA scaffold functionality.
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DB square and rectangle origami The square and rectangle origami designs estab-
lish a simpler raster-like scaffold disposition, in this design the staples domains are always
close enough to avoid the problem presented by the DB triangle design.
The DB origami rectangle (R1) immediately showed an unexpected behavior when per-
forming the classic folding protocol, forming a large misfolded agglomerate during the
denaturation step. This issue brought to a deep investigation of the folding process that
resulted in an improved isothermal protocol, adopted for all the later designs, that does
not require a denaturation step. The RNA scaffold was also optimized removing the lac
operon at the 5’ and the T7 terminator at the 3’, these sequences were initially included
prospecting the in vivo application, providing only a further degree of complexity to the
in vitro stage. The new sequence (DB 981) became the standard RNA scaffold for the
hybrid origami. These solutions granted an excellent folding rate demonstrated by the
AFM imaging. The tweaking of scaffold and staples ratio, brought up from 1:10 to 1:50,
further improved the results at the expenses of resource economy.
The DB square was designed to test an origami super-structure, relying on the use of linker
staples binding the origami in a chessboard assembly. While the gel results showed an
encouraging pattern, the AFM imaging could not visualize a proper formation, it showed
instead the deposition of large scale crystals of unknown origin. Due to the good results
obtained with the R1 origami, it was chosen to branch out in that direction, postponing
the super-structure enquiry until the folding mechanics will be properly investigated.
8.1.3 De Bruijn scaffold validation conclusions
The experiments on the origami folding clearly demonstrate that a DB sequence can
be used as a scaffold. Moreover, it’s clear that the thermodynamical optimization and
unique addressability, exclusive features of an arbitrary synthetic sequence, can be a great
advantage for working at in vivo compatible, lower temperatures: the origami folded using
the synthetic scaffolds were capable of an isothermal folding without the necessity of an
initial denaturation step as the biological sequences used before. With a proper sequence
design it will be possible to perform all the folding steps at temperatures compatible with
cellular cultures.
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8.2 In vivo DB scaffold study
The last feature that needed confirmation was the bio-orthogonality, theoretically ob-
tained by removing all the known biological sequences from the DB scaffolds.
Investigating the absence of general biological activities and interactions it is clearly not a
self-contained procedure. It is possible, though, to set-up an experiment that covers some
of the most important aspects for some of the species of interest. In this case the cloning
of the DB sequences, as 5’ untranslated regions between a promoter and a sfGFP reporter
gene, showed that bio-orthogonality is a complex matter that cannot be fully predicted
by the actual knowledge. The experiments were designed and performed on E. coli
8.2.1 pBAD33 construct
The first version of this experiment involved the use of a pBAD33 expression plasmid and
different E. coli strains (E. coli 5α, MG1655 and BL21 (DE3)). Relying on E. coli native
transcription machinery, the pBAD33-DB 2.4-sfGFP construct and its control (a random
dnaE fragment of the same length) clearly showed no expression at all when analysed
through flow cytometry. Probably, the extension of the non-coding sequence after the
promoter reduced the RNA polymerase processivity, suppressing the sfGFP expression,
at the same time it was noted that the DB 2.4 sequence had no transcription activating
effects.
8.2.2 pET-28a constructs
A functional transcription-translation system was obtained by cloning the DB-sfGFP
constructs in a pET-28a plasmid. This plasmid relies on a T7 RNA polymerase for its
gene transcription and the DB sequences already contained the T7 promoter sequences
by design for the in vitro synthesis. For these experiments, an E. coli T7 express strain
was used.
Using pET-28a made immediately clear that the sfGFP expression was restored in both
DB sequence and the control sequence constructs. Unexpectedly the first results showed
also that DB 2.4 has a negative effect on the associated sfGFP expression compared
to dnaE and sfGFP alone. Identifying the cause of the fluorescence reduction is not a
trivial matter, the lack of similar recorded sequences makes any bioinformatic analysis
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useless, and the absence of strong secondary structures, avoided by design, suggests that
it does not depend on RNA polymerase dissociation by structural impairment. This
analysis leaves a question mark on the true bio-orthogonality of DB 2.4 sequence and
only analysing the single fragments composing it could shed a light on this unpredicted
effect.
The same analysis performed on DB 981 produced a completely different result, in this case
the DB sequence performed better than the corresponding dnaE fragment and slightly
worst than sfGFP alone, pointing towards the initial hypothesis of bio-compatibility and
bio-orthogonality.
8.2.3 In vivo DB scaffold study conclusions
The confirmation of bio-orthogonality provided a mixed set of results. Further investi-
gations are necessary to understand the behavior expressed by DB 2.4, while DB 981
performances do not arise reasons for concern.
Though, the definitive proof of bio-orthogonality can only be provided through the ex-
tensive use of DB sequences in in vivo applications, over a larger number of organisms.
At the moment only this kind of proof-of-concept experiments are viable, with their clear
analytical limitations.
8.3 Origami folding thermodynamics analysis tool
Designing an origami application, that could help to better understand the thermody-
namics of the origami folding and at the same time could pave the way towards its in
vivo synthesis, seems a natural step forward, covering all the topics presented in my
thesis. Combining a functionalized origami, that generates a fluorescent signal upon its
folding, with the giant unilamellar vesicles synthesis, it is possible to create a cell-like
system that allows the tracking of the origami folding using advanced instruments such
as flow cytometers. At the same time, they can be used to simulate a simplified cellular
environment in preparation for the final in vivo synthesis.
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8.3.1 DB origami reporter
Three alternative solutions were tested for the generation of the DB origami folding re-
porter prototype. All of them are based on the DB R1 origami design, being the most
efficient in terms of synthesis and folding.
The first two designs involve the use of staples functionalized with fluorescent split RNA
aptamers that regenerate themselves upon the correct origami folding. The last one takes
advantage of the FRET effect between Cy3 and Cy5 modified staples.
Broccoli aptamer The origami reporter using the Broccoli aptamer as fluorescence
generator performed very well in regeneration tests showing a powerful signal. The
DFHBI-1T molecule interacts only with the regenerated split aptamer and can permeate
cellular membranes for in vivo experiments, furthermore Broccoli aptamer is compatible
with the origami folding buffer. The molecule is potentially perfect for this role but it
resulted incompatible with the R1 origami design, and more specifically, with the DB
scaffolds thermodynamical optimizations: the aptamer structure includes a hairpin stem
with a minimal free energy higher than any of the staple secondary structures, when in the
folding mix, the annealing of the two aptamer halves happens spontaneously generating
the signal without the actual origami folding.
A software analysis of the free energy of all the possible staple-aptamer combinations
individuated two couples compatible with a shorter hairpin stem, 17-30 and 24-20. The
shorter hairpin demonstrated to be sufficient to avoid the spontaneous regeneration and
the two aptamers were tested on the origami folding, the folding results showed that only
17-30 split regenerates on the origami. The last couple left was finally tested in a pilot ex-
periment: the fluorescence signals of the folded reporter origami and its unfolded version
were measured using a plate reader, the unexpected results showed no difference between
the samples. The reason is to be found again in the optimization of the DB sequence, it
promotes a partial folding of the origami also at sub-optimal temperatures allowing the
annealing of the aptamer-modified 17-30 staples and the consequent fluorescence.
Malachite green aptamer The second reporter relies on another split aptamer re-
generation, the malachite green. The free energy simulation was performed in advance
identifying three possible staple couples compatible with the split aptamer modification:
8.3. ORIGAMI FOLDING THERMODYNAMICS ANALYSIS TOOL 147
again 17-30 and 24-20, as for Broccoli, plus 4-6. Having a much more unstable sequence
this aptamer did not regenerate spontaneously but the regeneration tests performed in
agarose gel showed a good fluorescence/background ratio for 24-20 and 4-6 couples and
no signal for 17-30. When tested in the origami using the folding buffer, with a lower ion
concentration, all three couples worked again but the signal to background ratio became
much worst and almost undetectable. This critical flaw obviously limits the applicability
of the system, precluding the objective for which it is designed. Nonetheless, another
plate reader experiment was performed, and again the unfolded control origami showed
a similar signal to the folded one. To confirm the finding all the plate reader samples
were loaded in an agarose gel electrophoresis, showing indeed the formation of a partially
folded origami at room temperature
FRET The last DB origami folding reporter uses a completely different signal system:
two couples of staples, 13-3 and 26-25, are functionalized with fluorescent molecules, each
couple has one Cy-3 and one Cy-5 modification. When the origami folds the fluorescent
molecules lie 5 nt away from each other and the Cy-3 emission activates Cy-5 fluorescence
through the FRET effect. Because this system does not require any extra oligonucleotide
modification the risk of a false positive is reduced and the buffer composition does not
affect the efficiency of the reporters. Due to the intrinsic staple design, the two couples
could only be tested in the full origami folding and not as single couples. The first at-
tempt showed that a ratio of 10 fluorescent staples per 1 scaffold generates a disrupting
background signal. Using a 1:1 ratio improved the signal to noise ratio by a greater extent
but also showed a structural instability of the staple 25 Cy-5 producing a partial false
negative result requiring the removal of the 26-25 couple. Also in this case, the final
working design contemplated a single efficient signaling couple.
The plate reader experiment was performed also for this final reporter. Depending on
the DB scaffold design, this system suffered again from the partial folding of the con-
trol origami. Still, the folded origami FRET signal remained higher than the partially
folded control, probably because these fluorescent staples do not anneal efficiently at room
temperature.
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8.3.2 Giant unilamellar vesicles
The other component of this experiment is the giant unilamellar vesicle, an artificial li-
posome that can be loaded with a variety of different cargo and behaves as a simple
proto-cell. I only had the chance to perform a few preliminary tests in order to set-up the
first synthesis protocols.
In the first experiment, a neutrally charged POPC vesicle loaded with a GFP solution was
generated and visualized under a fluorescence microscope. As expected the GUV showed
an excellent synthesis yield, a good fluorescence signal and a prolonged stability.
In the second attempt, a mix of POPC and the negatively charged PEG2000 PE phos-
pholipid was used to generate a set of vesicles loaded with a solution of folded DB R1
non-fluorescent origami. The PEG2000 PE addition further increased the vesicles ef-
ficiency, unfortunately, the unavailability of a fluorescent origami signal prevented the
origami identification; it must be noted, though, that the synthesis protocol starts with
the formation of the cargo solution droplets, making unavoidable the origami presence
inside the final product.
The third and last version used a mix of POPC and DOTAP, a positively charged lipid.
This time, while the empty vesicles formed, the origami loaded ones could not be syn-
thesized. It is possible that the interaction between the positive lipid and the negative
nucleic acids unbalanced the conditions for the vesicles formation.
8.3.3 Origami folding thermodynamics analysis tool conclusions
Being in the embryonic stage, few practical conclusions can be drawn from this set of ex-
periments. It is clear that the DB R1 origami reporter is not the optimal structure to mea-
sure the folding process, the extreme folding optimization does not provide a controlled
process, making the measurements very difficult, if not inaccurate. This demonstrates
that the origami designs must be tailored for a specific goal. Under this point of view
a DB synthetic sequence has a great advantage: the algorithm generates a large number
of different sequences with different characteristics and the user can choose the one that
suits its needs. On the contrary, a biological sequence is rather static and requires a great
amount of modifications to radically change its behavior.
Both the aptamers and the FRET system showed a huge potential, coupled to a dedicated
origami design they can easily generate more reliable reporters.
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The giant unilamellar vesicles are a promising vessel for the origami analysis, being widely
used in the last 40 years they are a flexible but reliable tool that works well with nucleic
acids. The formation of vesicles loaded with origami is just the first step, but a relevant
one, that supports the worth of this application.
8.4 Future work
Many are the research paths that could stem from my experiments, some of the results
provided the inspiration for new potential applications and some of the questions still
deserve a deeper investigation.
ssDNA synthesis The ssDNA DB scaffold synthesis could be tested on a rolling circle
amplification in vivo, protocols for the generation of scaffolds and staples were already
published but none of them has the capacity to fold at life-compatible temperatures and
requiring an extraction and purification to be used in vitro. On the other hand, a DB
scaffold could be designed for this purpose attempting the first in vivo folding. A DNA
scaffold also has the advantage of being more stable and less susceptible to nucleases,
while RNA will be probably limited to mutated bacterial strains with a reduced RNase
activity.
Bio-orthogonality The DB scaffold still requires a better characterization of its bio-
orthogonality. DB 2.4 DNA scaffold can be fragmented and analysed to detect which
subsequence hinder the transcription of its construct. Also, more DB sequences can be
tested to see if any pattern arises and which is the statistical incidence of interfering
products. Obviously, the bio-orthogonality of a sequence is not only connected to the
transcription machinery and, as said before, it will be necessary a wider application of in
vivo DB sequences to have a complete picture.
DB origami folding reporter The folding reporter issues highlighted the necessity for
a more focused development of applicable origami. A more reliable origami that folds at a
predetermined temperature, not only solves this specific research problem, but can be also
considered a proper molecular switch. Combining a temperature responsive origami with
the split aptamer technology will make possible the creation of an artificial controllable
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enzyme based on nucleic acids.
Origami folding analysis tool The experiments on the folding analysis tool are the
most natural continuation of this research, as previously outlined there are two main
possible paths involving GUVs and origami.
The first is the creation of a system that allows understanding how the origami folding
happens. Different fluorescent reporters on the same origami could describe the temporal
sequence of the staples annealing during the folding, the results can be used to improve
or confirm the computational models. In this case, the vesicles could accomplish two
purposes, they can allow the use of high throughput machines to analyse the origami, but
they can also control the origami folding reaction: different GUVs carrying the separate
origami components can be fused together in a controlled manner starting the folding
only when required.
The second path considers the GUVs as proto-cells and uses them to gradually get closer
to the in vivo origami synthesis. Instead of trying the folding directly inside a living cell,
with many uncontrolled variables, smaller steps are performed inside the liposomes. Using
buffers, cell-free extracts and raw extracts it could be possible to consider the potential
variables individually or at least in smaller groups. Nucleic acid origami are still a young
technology and their true potential is not yet expressed, the next big leap will coincide
with their synthesis in vivo and the repercussions will involve all the biology fields, from
the industrial biotechnology to the molecular medicine.
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